UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)


☒			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~March 31,~~September 30, 2021


☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number: ~~333-161943~~001-40477

Better Choice Company Inc.

(Exact name of registrant as specified in its charter)


Delaware			83-4284557
(State or other jurisdiction of incorporation or organization)			(I.R.S. Employer Identification No.)

12400 Race Track Road

Tampa, Florida 33626

(Address of Principal Executive Offices) (Zip Code)

(Registrant’s Telephone Number, Including Area Code): ~~(813) 659-5921~~(212) 896-1254

Securities registered pursuant to Section 12(b) of the Act:


Title of Each Class	Trading Symbol(s)	Name of Each Exchange on which Registered
~~N/A~~Common Stock, $0.001 par value share	~~N/A~~BTTR	~~N/A~~NYSE American

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by checkmark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

*(As a voluntary filer, the registrant has not been subject to the filing requirements of Section 13 or 15(d) of the Exchange Act for the past 90 days. The registrant has filed all reports required under Section 13 or 15(d) of the Exchange Act during the preceding 12 months).

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by checkmark whether the registrant is a large accelerated filer, accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

☐

Accelerated filer

☐

Non-accelerated filer

☒

Smaller reporting company

☒

Emerging growth company

☐

If an emerging growth company, indicate by a check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by a check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).Yes ☐ No ☒

The number of shares outstanding of each of the registrant’s classes of common stock as of the latest practicable date was: ~~66,028,348~~29,241,317 shares of $0.001 par value common stock outstanding as of ~~May 7,~~November 8, 2021.

Table of Contents

Better Choice Company Inc.

Table of Contents


Item	Item		Page	Item		Page
		PART I – FINANCIAL INFORMATION			PART I – FINANCIAL INFORMATION
1.	1.	Financial Statements	4	1.	Financial Statements	4
2.	2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	23	2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	24
3.	3.	Quantitative and Qualitative Disclosures About Market Risk	28	3.	Quantitative and Qualitative Disclosures About Market Risk	30
4.	4.	Controls and Procedures	28	4.	Controls and Procedures	30
		PART II – OTHER INFORMATION			PART II – OTHER INFORMATION
1.	1.	Legal Proceedings	29	1.	Legal Proceedings	30
1A.	1A.	Risk Factors	29	1A.	Risk Factors	30
2.	2.	Unregistered Sales of Equity Securities and Use of Proceeds	29	2.	Unregistered Sales of Equity Securities and Use of Proceeds	31
3.	3.	Defaults Upon Senior Securities	29	3.	Defaults Upon Senior Securities	31
4.	4.	Mine Safety Disclosures	29	4.	Mine Safety Disclosures	31
5.	5.	Other Information	29	5.	Other Information	31
6.	6.	Exhibits	29	6.	Exhibits	31
		Signatures	33		Signatures	35

FORWARD-LOOKING STATEMENTS

This Quarterly Report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements other than statements of historical facts contained in this Quarterly Report on Form 10-Q ("Quarterly Report") are “forward-looking statements” for purposes of federal and state securities laws, including statements regarding our expectations and projections regarding future developments, operations and financial conditions, and the anticipated impact of COVID-19 and our acquisitions, business strategy and strategic priorities. These statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements.

In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “expect,” “plan,” “anticipate,” “could,” “intend,” “target,” “project,” “contemplate,” “believe,” “estimate,” “predict,” “potential,”or “continue,”or the negative of these terms or other similar expressions, although not all forward-looking statements contain these words. The forward-looking statements in this Quarterly Report are only predictions and are based largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition and results of operations. Forward-looking statements contained herein include, among others, statements concerning management's expectations about future events, ~~and the Company’s~~ operating plans and performance, the effects of the COVID-19 outbreak, including levels of consumer, business and economic confidence generally, the regulatory environment, litigation, sales and the expected benefits of acquisitions, and such statements are based on the current beliefs and expectations of ~~the Company’s~~ management, as ~~applicable, and are subject to known and unknown risks and uncertainties.~~applicable. These forward-looking statements speak only as of the date of this Quarterly Report and are subject to a number of known and unknown risks, uncertainties, and assumptions. Although we believe the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and inherent risks and uncertainties.

~~These forward-looking statements present our estimates and assumptions only as of the date of this Quarterly Report.~~ Accordingly, you are cautioned not to place undue reliance on forward-looking statements, which speak only as of the dates on which they are made. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances, or otherwise. We qualify all of our forward looking statements by these cautionary statements. You should, however, consult further disclosures we make in future filings and public disclosures, including without limitation, our Annual Report on Form 10-K ("Annual Report"), Quarterly Reports on Forms 10-Q, and Current Reports on Forms 8-K.

Table of Contents

Important factors that could cause actual results to differ materially from those in the forward-looking statements include, but are not limited to, those summarized below:

•the impact of COVID-19 on the U.S. and global economies, our employees, suppliers, customers and end consumers, which could adversely and materially impact our business, financial condition and results of operations

•our ability to successfully implement our growth strategy;

•failure to achieve growth or manage anticipated growth;

•our ability to achieve or maintain profitability;

•~~our significant indebtedness;~~

•the loss of key members of our senior management team;

•our ability to generate sufficient cash flow or raise capital on acceptable terms to run our operations, service our debt and make necessary capital expenditures;

•our ability to maintain effective internal control over financial reporting;

•~~our limited operating history;~~

•our ability to successfully integrate Halo’s and TruPet’s businesses and realize anticipated benefits with these acquisitions and with other acquisitions or investments we may make;

•our dependence on our subsidiaries for payments, advances and transfers of funds due to our holding company status;

•our ability to successfully develop additional products and services or successfully market and commercialize such products and services;

•competition in our market;

•our ability to attract new and retain existing customers, suppliers, distributors or retail partners;

•allegations that our products cause injury or illness or fail to comply with government regulations;

•our ability to manage our supply chain effectively;

•our or our third-party contract manufacturers’ and suppliers’ ability to comply with legal and regulatory requirements;

•the effect of potential price increases and shortages on the inputs, commodities and ingredients that we require;

•our ability to develop and maintain our brand and brand reputation;

•compliance with data privacy rules;

•our compliance with applicable regulations issued by the U.S. Food and Drug Administration (“FDA”), the U.S. Federal Trade Commission (“FTC”), the U.S. Department of Agriculture (“USDA”), and other federal, state and local regulatory authorities, including those regarding marketing pet food, products and supplements;

•risk of our products being recalled for a variety of reasons, including product defects, packaging safety and inadequate or inaccurate labeling disclosure;

•risk of shifting customer demand in relation to raw pet foods, premium kibble and canned pet food products, and failure to respond to such changes in customer taste quickly and effectively; and

•the other risks identified in this ~~prospectus~~Quarterly Report including, without limitation, Part I, Item 2 “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and Part II, Item 1A “Risk Factors” as such factors may updated from time to time in our other public filings.

Given these uncertainties, you should not place undue reliance on these forward looking statements. These forward looking statements represent our estimates and assumptions only as of the date of this report and, except as required by law, we undertake no obligation to update or revise publicly any forward looking statements, whether as a result of new information, future events or otherwise after the date of this report. We qualify all of our forward looking statements by these cautionary statements. You should, however, consult further disclosures we make in future filings and public disclosures, including without limitation, our Annual Report on Form 10-K ("Annual Report"), Transition Report on Form 10-KT, Quarterly Reports on Forms 10-Q, and Current Reports on Forms 8-K.

Table of Contents

PART I

ITEM 1. FINANCIAL STATEMENTS

Better Choice Company Inc.

Unaudited Condensed Consolidated Statements of Operations

(Dollars in thousands, except share and per share amounts)


	Nine Months Ended September 30,				Three Months Ended September 30,
	2021		2020		2021		2020
Net sales	$	35,019	$	33,302	$	13,200	$	11,135
Cost of goods sold	22,407		20,563		8,762		6,678
Gross profit	12,612		12,739		4,438		4,457
Operating expenses:
General and administrative	11,778		23,158		3,727		3,545
Sales and marketing	9,619		6,847		4,018		2,650
Share-based compensation	3,517		7,047		660		1,543
Total operating expenses	24,914		37,052		8,405		7,738
Loss from operations	(12,302)		(24,313)		(3,967)		(3,281)
Other expense (income):
Interest expense, net	3,148		7,268		79		2,537
(Gain) Loss on extinguishment of debt, net	(457)		88		—		88

Change in fair value of warrant liabilities	(23,463)		(2,118)		(590)		(4,213)
Total other (income) expense, net	(20,772)		5,238		(511)		(1,588)
Net income (loss)	8,470		(29,551)		(3,456)		(1,693)
Preferred dividends	—		103		—		35
Net income (loss) available to common stockholders	$	8,470	$	(29,654)	$	(3,456)	$	(1,728)

Weighted average number of shares outstanding, basic	16,799,796		8,134,957		29,466,520		8,160,242
Weighted average number of shares outstanding, diluted	23,685,351		8,134,957		29,466,520		8,160,242
Earnings (loss) per share, basic	$	0.48	$	(3.65)	$	(0.12)	$	(0.21)
Earnings (loss) per share, diluted	$	0.34	$	(3.65)	$	(0.12)	$	(0.21)

See accompanying notes to the unaudited condensed consolidated financial statements.

Table of Contents

Better Choice Company Inc.

Condensed Consolidated Balance Sheets

(Dollars in thousands, except share and per share amounts)


		March 31, 2021		December 31, 2020			September 30, 2021		December 31, 2020
		Unaudited		Audited			Unaudited		Audited
Assets	Assets					Assets
Cash and cash equivalents	Cash and cash equivalents	$	4,298	$	3,926	Cash and cash equivalents	$	26,048	$	3,926
Restricted cash	Restricted cash	63		63		Restricted cash	7,213		63
Accounts receivable, net	Accounts receivable, net	6,675		4,631		Accounts receivable, net	7,524		4,631
Inventories, net	Inventories, net	4,582		4,869		Inventories, net	3,424		4,869

Prepaid expenses and other current assets	Prepaid expenses and other current assets	4,258		4,074		Prepaid expenses and other current assets	3,726		4,074
Total Current Assets	Total Current Assets	19,876		17,563		Total Current Assets	47,935		17,563
Property and equipment, net	Property and equipment, net	205		252		Property and equipment, net	168		252
Right-of-use assets, operating lease		305		345
Right-of-use assets, operating leases						Right-of-use assets, operating leases	68		345
Intangible assets, net	Intangible assets, net	12,732		13,115		Intangible assets, net	11,968		13,115
Goodwill	Goodwill	18,614		18,614		Goodwill	18,614		18,614
Other assets	Other assets	635		1,364		Other assets	114		1,364
Total Assets	Total Assets	$	52,367	$	51,253	Total Assets	$	78,867	$	51,253
Liabilities & Stockholders’ Deficit
Liabilities & Stockholders’ Equity (Deficit)						Liabilities & Stockholders’ Equity (Deficit)
Current Liabilities	Current Liabilities					Current Liabilities
Term loans, net	Term loans, net	$	628	$	7,826	Term loans, net	$	780	$	7,826

PPP loans	PPP loans	315		190		PPP loans	—		190
Other liabilities		41		47
Accrued and other liabilities						Accrued and other liabilities	1,607		3,400
Accounts payable	Accounts payable	5,221		3,137		Accounts payable	4,047		3,137
Accrued liabilities		2,090		3,003
Deferred revenue		257		350

Operating lease liability	Operating lease liability	180		173		Operating lease liability	52		173
Warrant liabilities		46,333		39,850
Warrant liability						Warrant liability	—		39,850
Total Current Liabilities	Total Current Liabilities	55,065		54,576		Total Current Liabilities	6,486		54,576
Non-current Liabilities	Non-current Liabilities					Non-current Liabilities
Notes payable, net	Notes payable, net	19,609		18,910		Notes payable, net	—		18,910
Term loans, net	Term loans, net	5,219		0		Term loans, net	4,779		—
Lines of credit, net	Lines of credit, net	4,781		5,023		Lines of credit, net	4,846		5,023
PPP loans	PPP loans	537		662		PPP loans	—		662
Operating lease liability	Operating lease liability	136		184		Operating lease liability	19		184
Total Non-current Liabilities	Total Non-current Liabilities	30,282		24,779		Total Non-current Liabilities	9,644		24,779
Total Liabilities	Total Liabilities	85,347		79,355		Total Liabilities	16,130		79,355
Stockholders’ Deficit
Common stock, $0.001 par value, 200,000,000 shares authorized, 66,004,348 and 51,908,398 shares issued and outstanding as of March 31, 2021 and December 31, 2020, respectively		66		52
Series F Preferred Stock, $0.001 par value, 30,000 shares authorized, 17,306 and 21,754 shares issued and outstanding as of March 31, 2021 and December 31, 2020, respectively		0		0
Stockholders’ Equity (Deficit)						Stockholders’ Equity (Deficit)
Common Stock, $0.001 par value, 200,000,000 shares authorized, 29,241,317 and 8,651,400 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively						Common Stock, $0.001 par value, 200,000,000 shares authorized, 29,241,317 and 8,651,400 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively	29		9
Series F Preferred Stock, $0.001 par value, 30,000 shares authorized, — shares and 21,754 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively						Series F Preferred Stock, $0.001 par value, 30,000 shares authorized, — shares and 21,754 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively	—		—
Additional paid-in capital	Additional paid-in capital	240,847		232,487		Additional paid-in capital	316,554		232,530
Accumulated deficit	Accumulated deficit	(273,893)		(260,641)		Accumulated deficit	(253,846)		(260,641)
Total Stockholders’ Deficit		(32,980)		(28,102)
Total Liabilities and Stockholders’ Deficit		$	52,367	$	51,253
Total Stockholders’ Equity (Deficit)						Total Stockholders’ Equity (Deficit)	62,737		(28,102)
Total Liabilities and Stockholders’ Equity (Deficit)						Total Liabilities and Stockholders’ Equity (Deficit)	$	78,867	$	51,253

See accompanying notes to the unaudited condensed consolidated financial statements.

~~Table of Contents~~

~~Better Choice Company Inc.~~

~~Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss~~

~~(Dollars in thousands, except share and per share amounts)~~

Three Months Ended March 31,
2021 2020
Net sales $ 10,830 $ 12,226
Cost of goods sold 6,556 8,069
Gross profit 4,274 4,157
Operating expenses:
General and administrative 4,551 8,245
Share-based compensation 2,525 2,485
Sales and marketing 2,336 1,959
Total operating expenses 9,412 12,689
Loss from operations (5,138) (8,532)
Other expense (income):
Interest expense 835 2,301
Loss on extinguishment of debt 394 0
Change in fair value of warrant liabilities 6,483 (1,379)
Total other expense, net 7,712 922
Net and comprehensive loss (12,850) (9,454)
Preferred dividends 0 34
Net and comprehensive loss available to common stockholders $ (12,850) $ (9,488)
Weighted average number of shares outstanding, basic and diluted 57,525,054 48,526,396
Loss per share, basic and diluted $ (0.23) $ (0.20)

~~See accompanying notes to the unaudited condensed consolidated financial statements.~~

Table of Contents

Better Choice Company Inc.

Unaudited Condensed Consolidated Statements of Stockholders’ ~~Deficit~~Equity (Deficit)

(Dollars in thousands except shares)


		Common Stock			Series F Convertible Preferred Stock										Common Stock			Series F Convertible Preferred Stock
		Shares	Amount		Shares	Amount		Additional paid-in capital		Accumulated deficit		Total Stockholders’ Deficit			Shares	Amount		Shares	Amount		Additional Paid-In Capital		Accumulated Deficit		Total Stockholders’ (Deficit) Equity
Balance as of December 31, 2020	Balance as of December 31, 2020	51,908,398	$	52	21,754	$	0	$	232,487	$	(260,641)	$	(28,102)	Balance as of December 31, 2020	8,651,400	$	9	21,754	$	—	$	232,530	$	(260,641)	$	(28,102)
Shares and warrants issued pursuant to private placement	Shares and warrants issued pursuant to private placement	3,280,400	3		—	—		4,069		—		4,072		Shares and warrants issued pursuant to private placement	546,733	1		—	—		4,071		—		4,072
Share-based compensation	Share-based compensation	105,222	—		—	—		2,544		—		2,544		Share-based compensation	17,537	—		—	—		2,544		—		2,544
Warrant exercises	Warrant exercises	1,784,298	2		—	—		1,308		—		1,310		Warrant exercises	297,383	—		—	—		1,310		—		1,310
Shares issued to third-party for services	Shares issued to third-party for services	30,000	—		—	—		46		—		46		Shares issued to third-party for services	5,000	—		—	—		46		—		46
Warrant modifications	Warrant modifications	—	—		—			402		(402)		0		Warrant modifications	—	—		—			402		(402)		—
Conversion of Series F shares to common stock	Conversion of Series F shares to common stock	8,896,030	9		(4,448)	—		(9)		—		—		Conversion of Series F shares to common stock	1,482,672	1		(4,448)	—		(1)		—		—
Net and comprehensive loss available to common stockholders		—	—		—	—		—		(12,850)		(12,850)
Net loss available to common stockholders														Net loss available to common stockholders	—	—		—	—		—		(12,850)		(12,850)
Balance as of March 31, 2021	Balance as of March 31, 2021	66,004,348	$	66	17,306	$	0	$	240,847	$	(273,893)	$	(32,980)	Balance as of March 31, 2021	11,000,725	$	11	17,306	$	—	$	240,902	$	(273,893)	$	(32,980)

Warrant exercise														Warrant exercise	83,333	—		—	—		375		—		375
Conversion of Series F shares to common stock														Conversion of Series F shares to common stock	4,000	—		(12)	—		—		—		—
Conversion of convertible notes to common stock														Conversion of convertible notes to common stock	4,732,420	5		—	—		21,771		—		21,776
Share-based compensation														Share-based compensation	—	—		—	—		313		—		313
Shares issued in lieu of fractional shares due to reverse stock split														Shares issued in lieu of fractional shares due to reverse stock split	1,081	—		—	—		—		—		—
Net income available to common stockholders														Net income available to common stockholders	—	—		—	—		—		24,776		24,776
Balance as of Balance as of June 30, 2021														Balance as of Balance as of June 30, 2021	15,821,559	$	16	17,294	$	—	$	263,361	$	(249,117)	$	14,260
Shares issued pursuant to IPO														Shares issued pursuant to IPO	8,000,000	8		—	—		36,152		—		36,160
Conversion of Series F shares to common stock														Conversion of Series F shares to common stock	5,764,533	6		(17,294)	—		(6)		—		—
Reclassification of warrant liability to equity														Reclassification of warrant liability to equity	—	—		—	—		16,387		—		16,387
Share repurchases														Share repurchases	(344,775)	(1)		—	—		—		(1,273)		(1,274)
Share-based compensation														Share-based compensation	—	—		—	—		660		—		660
Net loss available to common stockholders														Net loss available to common stockholders	—	—		—	—		—		(3,456)		(3,456)
Balance as of Balance as of September 30, 2021														Balance as of Balance as of September 30, 2021	29,241,317	$	29	—	$	—	$	316,554	$	(253,846)	$	62,737

Common Stock Redeemable Series E
Convertible Preferred Stock
Shares Amount Additional
Paid-In
Capital Accumulated
Deficit Total
Stockholders’
Deficit Shares Amount
Balance as of December 31, 2019 47,977,390 $ 48 $ 194,150 $ (201,269) $ (7,071) 1,387,378 $ 10,566
Shares issued pursuant to a private placement 308,642 — 500 — 500 — —
Share-based compensation 455,956 1 2,484 — 2,485 — —
Shares and warrants issued to third party for contract termination 72,720 — 198 — 198 — —
Shares issued to third parties for services 125,000 — 125 — 125 — —
Warrants issued to third parties for services — — 2,594 — 2,594 — —
Net and comprehensive loss available to common stockholders — — — (9,488) (9,488) — —
Balance as of March 31, 2020 48,939,708 $ 49 $ 200,051 $ (210,757) $ (10,657) 1,387,378 $ 10,566

Table of Contents


	Common Stock									Redeemable Series E Convertible Preferred Stock
	Shares	Amount		Additional Paid-In Capital		Accumulated Deficit		Total Stockholders’ Deficit		Shares	Amount
Balance as of December 31, 2019	7,996,232	$	8	$	194,190	$	(201,269)	$	(7,071)	1,387,378	$	10,566
Shares issued pursuant to a private placement	51,440	—		500		—		500		—	—
Share-based compensation	75,993	1		2,484		—		2,485		—	—
Shares and warrants issued to third party for contract termination	12,120	—		198		—		198		—	—
Shares issued to third parties for services	20,833	—		125		—		125		—	—
Warrants issued to third parties for services	—	—		2,594		—		2,594		—	—
Net loss available to common stockholders	—	—		—		(9,488)		(9,488)		—	—
Balance as of March 31, 2020	8,156,618	$	9	$	200,091	$	(210,757)	$	(10,657)	1,387,378	$	10,566
Warrants issued to third parties for services	—	—		7,390		—		7,390		—	—
Share-based compensation	—	—		3,020		—		3,020		—	—
Warrants issued in connection with June 2020 Notes	—	—		337		—		337		—	—
Beneficial conversion feature of June 2020 Notes	—	—		1,163		—		1,163		—	—
Modification of conversion feature for November 2019 Notes, Seller Notes, and ABG Notes	—	—		528		—		528		—	—
Modification of warrants	—	—		43		—		43		—	—
Net loss available to common stockholders	—	—		—		(18,438)		(18,438)		—	—
Balance as of June 30, 2020	8,156,618	$	9	$	212,572	$	(229,195)	$	(16,614)	1,387,378	$	10,566
Shares issued pursuant to warrant exercise	33,334	—		—		—		—		—	—
Share-based compensation	—	—		1,543		—		1,543		—	—
Warrants issued in connection with ABL Facility	—	—		230		—		230		—	—
Net loss available to common stockholders	—	—		—		(1,728)		(1,728)		—	—
Balance as of September 30, 2020	8,189,952	$	9	$	214,345	$	(230,923)	$	(16,569)	1,387,378	$	10,566

See accompanying notes to the unaudited condensed consolidated financial statements.

Table of Contents

Better Choice Company Inc.

Unaudited Condensed Consolidated Statements of Cash Flows

(Dollars in thousands)


		Three Months Ended March 31,					Nine Months Ended September 30,
		2021		2020			2021		2020
Cash Flow from Operating Activities:	Cash Flow from Operating Activities:					Cash Flow from Operating Activities:
Net and comprehensive loss available to common stockholders		$	(12,850)	$	(9,488)
Adjustments to reconcile net and comprehensive loss to net cash used in operating activities:
Net income (loss) available to common stockholders						Net income (loss) available to common stockholders	$	8,470	$	(29,654)
Adjustments to reconcile net income (loss) to net cash used in operating activities:						Adjustments to reconcile net income (loss) to net cash used in operating activities:
Shares and warrants issued to third parties for services	Shares and warrants issued to third parties for services	46		2,792		Shares and warrants issued to third parties for services	46		10,182

Depreciation and amortization	Depreciation and amortization	411		457		Depreciation and amortization	1,255		1,298
Amortization of debt issuance costs and discounts	Amortization of debt issuance costs and discounts	161		1,090		Amortization of debt issuance costs and discounts	1,785		3,723
Share-based compensation	Share-based compensation	2,544		2,485		Share-based compensation	3,517		7,047

Change in fair value of warrant liabilities	Change in fair value of warrant liabilities	6,483		(1,379)		Change in fair value of warrant liabilities	(23,463)		(2,118)
Payment In Kind (PIK) interest expense on notes payable		548		459
PIK interest expense on notes payable						PIK interest expense on notes payable	1,110		1,465

Amortization of prepaid advertising						Amortization of prepaid advertising	891		—
Other	Other	(92)		644		Other	(981)		772
Changes in operating assets and liabilities:	Changes in operating assets and liabilities:					Changes in operating assets and liabilities:
Accounts receivable, net	Accounts receivable, net	(2,044)		(297)		Accounts receivable, net	(2,893)		195
Inventories, net	Inventories, net	287		1,818		Inventories, net	1,445		1,458
Prepaid expenses and other assets	Prepaid expenses and other assets	545		5		Prepaid expenses and other assets	680		224

Accounts payable and accrued liabilities	Accounts payable and accrued liabilities	1,735		26		Accounts payable and accrued liabilities	(8)		691

Other	Other	(99)		229		Other	(174)		194
Cash Used in Operating Activities	Cash Used in Operating Activities	$	(2,325)	$	(1,159)	Cash Used in Operating Activities	$	(8,320)	$	(4,523)

Cash Flow from Investing Activities	Cash Flow from Investing Activities					Cash Flow from Investing Activities

Acquisition of property and equipment	Acquisition of property and equipment	$	0	$	(8)	Acquisition of property and equipment	$	(124)	$	(42)
Cash Used in Investing Activities	Cash Used in Investing Activities	$	0	$	(8)	Cash Used in Investing Activities	$	(124)	$	(42)

Cash Flow from Financing Activities	Cash Flow from Financing Activities					Cash Flow from Financing Activities
Proceeds from shares and warrants issued pursuant to private placement, net	Proceeds from shares and warrants issued pursuant to private placement, net	$	4,012	$	0	Proceeds from shares and warrants issued pursuant to private placement, net	$	4,012	$	—

Share repurchases						Share repurchases	(1,274)		—
Proceeds from issuance of debt						Proceeds from issuance of debt	—		2,352
Proceeds from revolving lines of credit	Proceeds from revolving lines of credit	5,155		500		Proceeds from revolving lines of credit	5,535		6,624
Payments on revolving lines of credit	Payments on revolving lines of credit	(5,584)		0		Payments on revolving lines of credit	(5,883)		(6,297)
Proceeds from term loan	Proceeds from term loan	6,000		0		Proceeds from term loan	6,000		—
Payments on term loans	Payments on term loans	(8,080)		0		Payments on term loans	(8,379)		—

Proceeds from investor prepayment						Proceeds from investor prepayment	—		1,518
Cash received for warrant exercises	Cash received for warrant exercises	1,310		0		Cash received for warrant exercises	1,685		—
IPO proceeds, net						IPO proceeds, net	36,160		—
Debt issuance costs	Debt issuance costs	(116)		0		Debt issuance costs	(140)		(85)
Cash Provided by Financing Activities	Cash Provided by Financing Activities	$	2,697	$	500	Cash Provided by Financing Activities	$	37,716	$	4,112

Net increase (decrease) in cash and cash equivalents and restricted cash		$	372	$	(667)
Total cash and cash equivalents and restricted cash, Beginning of Period		3,989		2,534
Total cash and cash equivalents and restricted cash, End of Period		$	4,361	$	1,867
Net (decrease) increase in cash and cash equivalents and restricted cash						Net (decrease) increase in cash and cash equivalents and restricted cash	$	29,272	$	(453)
Total cash and cash equivalents and restricted cash, beginning of period						Total cash and cash equivalents and restricted cash, beginning of period	3,989		2,534
Total cash and cash equivalents and restricted cash, end of period						Total cash and cash equivalents and restricted cash, end of period	$	33,261	$	2,081

Supplemental cash flow ~~information~~

Three Months Ended
March 31,
2021 2020
Cash paid during the period for:
Income taxes $ 0 $ 0
Interest $ 148 $ 613
Non-cash financing and investing transactions
Stock issued for services $ 0 $ 125
information:


	Nine Months Ended September 30,
	2021		2020
Cash paid during the period for:

Interest	$	292	$	1,729
Non-cash financing and investing transactions
Stock issued for services	$	—	$	125
ABL guarantor warrants	$	—	$	230

See accompanying notes to the unaudited condensed consolidated financial statements.

Table of Contents

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

Note 1 - Nature of business and summary of significant accounting policies

Nature of the ~~Business~~business

Better Choice Company Inc. (the "Company") is a growing ~~animal~~pet health and wellness company focused on providing pet products and services that help dogs and cats live healthier, happier and longer lives. The Company sells its product ~~offering~~offerings under the Halo and TruDog brands, which have a long history of providing high quality products to pet parents. The Company believes its portfolio of brands are well-positioned to benefit from the trends of growing pet humanization and an increased consumer focus on health and wellness, and the Company has adopted a laser focused, channel-specific approach to growth that is driven by new product innovation. The Company has a broad portfolio of ~~over 100 active~~ premium and super-premium ~~animal~~pet health and wellness products for dogs and cats sold under its Halo and TruDog brands across multiple forms, including foods, treats, toppers, dental products, chews, grooming products and supplements. The products consist of naturally formulated premium kibble and canned dog and cat food, freeze-dried raw dog food and treats, vegan dog food and treats, oral care products, supplements and grooming aids. The core products sold under the Halo brand are sustainably sourced, derived from real whole meat and no rendered meat meal and include non-genetically modified fruits and vegetables. The core products sold under the TruDog brand are made according to the Company's nutritional philosophy of fresh, meat-based nutrition and minimal processing.

Reverse stock split

On May 28, 2021, stockholders holding a majority of the voting power of the Company approved, by way of a written consent resolution, for the authorization of the Company's board of directors, in its sole and absolute discretion, and without further action of the stockholders, to file an amendment to the Company’s amended and restated certificate of incorporation to affect a reverse stock split of its common stock at a ratio in the range of 1-for-3 to 1-for-10 at any time prior to December 31, 2021. On June 10, 2021 the Company's board of directors set the reverse stock split ratio at 1-for-6 (the "Reverse Stock Split") and approved the Reverse Stock Split to be effectuated by the Company immediately following the effectiveness of the Company's registration statement related to the Company's IPO (as defined below), which became effective on June 28, 2021.

As a result of the Reverse Stock Split, every six shares of the Company’s common stock was combined and converted into one share of the Company’s common stock as of June 28, 2021. In addition, the conversion rates of the Company's outstanding preferred stock and convertible notes and the exercise prices of the Company’s underlying common stock purchase warrants and stock options were proportionately adjusted at the applicable reverse stock split ratio in accordance with the terms of such instruments. Proportionate voting rights and other rights of common stockholders were not affected by the Reverse Stock Split, other than as a result of the rounding up of fractional shares. The Company issued 1,081 shares of common stock in lieu of fractional shares in connection with the Reverse Stock Split.

Accordingly, all share and per share amounts related to the Company's common stock and underlying derivatives for all periods presented in the accompanying unaudited condensed consolidated financial statements and notes thereto have been retroactively adjusted, where applicable, to reflect the Reverse Stock Split. The number of authorized shares and the par values of the common stock and convertible preferred stock were not adjusted as a result of the Reverse Stock Split.

Initial public offering

On June 28, 2021, the Company’s registration statement on Form S-1 for its underwritten initial public offering (the “IPO”) was declared effective by the SEC, and the Company's common stock commenced trading on the NYSE American ("NYSE") on June 29, 2021. Upon commencement of the trading of the Company's common stock on the NYSE on June 29, 2021, all of the Company's outstanding convertible notes payable automatically converted into 4,732,420 shares of common stock.

In connection with the IPO, which closed on July 1, 2021, the Company issued and sold 8,000,000 shares of its common stock at a price of $5.00 per share. The total net proceeds from the IPO were approximately $36.2 million, after deducting underwriting discounts and commissions of $2.8 million, and offering costs of approximately $1.0 million. The Company plans to use the net proceeds of this IPO for general corporate purposes. The Company may also elect to use proceeds from the IPO to acquire complimentary technologies, products or businesses, although the Company is not a party to any letters of intent or definitive agreements for any such acquisition.

Upon the consummation of the IPO on July 1, 2021, all shares of the Series F convertible preferred stock were converted into 5,764,533 shares of common stock. Additionally, since the anti-dilution provision of the Series F Warrants were no longer effective upon consummation of the Company's IPO, these warrants met the requirements to be considered equity and the outstanding Series F Warrants were reclassified as such.

Table of Contents

Basis of ~~Presentation~~presentation

The Company’s condensed consolidated financial statements are prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) for interim financial reports and accounting principles generally accepted in the United States ("GAAP"). Results of operations for interim periods may not be representative of results to be expected for the full year.

Certain reclassifications have been made to conform the prior period data to the current presentation. These reclassifications had no material effect on the reported results.

These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes in the Company’s Annual Report for the year ended December 31, 2020, filed with the SEC.

Consolidation

The financial statements are presented on a consolidated basis subsequent to acquisitions and include the accounts of the Company and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.

Use of ~~Estimates~~estimates

The preparation of financial statements in conformity with ~~U.S.~~ GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting periods. The Company bases its estimates on historical experience and on various other assumptions that the Company believes to be reasonable under the circumstances. On an ongoing basis, the Company evaluates these assumptions, judgments and estimates. Actual results may differ from these estimates.

In the opinion of management, the condensed consolidated financial statements contain all adjustments necessary for a fair statement of the results of operations ~~and comprehensive loss~~ for the periods ended ~~March 31,~~September 30, 2021 and 2020, the financial position as of ~~March 31,~~September 30, 2021 and December 31, 2020 and the cash flows for the periods ended ~~March 31,~~September 30, 2021 and 2020.

~~Going Concern Considerations~~

The Company is subject to risks common in the pet wellness consumer market including, but not limited to, dependence on key personnel, competitive forces, successful marketing and sale of its products, the successful protection of its proprietary technologies, ability to grow into new markets, and compliance with government regulations. As of March 31, 2021, the Company has not experienced a significant adverse impact to its business, financial condition or cash flows resulting from the COVID-19 pandemic. However, uncertainties regarding the continued economic impact of COVID-19 are likely to result in sustained market turmoil which could also negatively impact the Company's business, financial condition, and cash flows in the future. The Company has continually incurred losses and has an accumulated deficit. The Company continues to rely on current investors and the public markets to finance these losses through debt and/or equity issuances. These operating losses, working capital deficit and the outstanding debt create substantial doubt about the Company’s ability to continue as a going concern for a period of twelve months from the date these condensed consolidated financial statements are issued.

~~Table of Contents~~

The Company is implementing plans to achieve cost savings and other strategic objectives to address these conditions. The Company expects cost savings from consolidation of third-party manufacturers, optimizing shipping and warehousing as well as overhead cost reductions. The business is focused on successful completion of capital raises and growing the most profitable channels while reducing investments in areas that are not expected to have long-term benefits. The accompanying condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and payments of liabilities in the ordinary course of business. Accordingly, the condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of asset carrying amounts or the amount of and classification of liabilities that may result should the Company be unable to continue as a going concern.

Summary of ~~Significant Accounting Policies~~significant accounting policies

For additional information, please refer to ~~our~~the most recently filed Annual Report regarding the Company's summary of significant accounting policies.

Cash and cash equivalents

Cash and cash equivalents include demand deposits held with banks and highly liquid investments with original maturities of ninety days or less at acquisition date. Cash and cash equivalents are stated at cost, which approximates fair value because of the short-term nature of these instruments. Our cash equivalents are held in government money market funds and at times may exceed federally insured limits. For purposes of reporting cash flows, the Company considers all cash accounts that are not subject to withdrawal restrictions or penalties to be cash and cash equivalents.

Restricted cash

The Company was required to maintain a restricted cash balance of less than $0.1 million as of September 30, 2021 and December 31, 2020, respectively, associated with a business credit card and credit card clearance operations. The Company was required to maintain a restricted cash balance of $7.2 million as of September 30, 2021 in connection with the amendment to the Wintrust Credit Facility (as defined below). See "Note 7 - Debt" for additional information.

Share repurchases

In August 2021, the Company's Board of Directors approved a share repurchase program that authorizes the repurchase of up to $2.0 million of the Company's outstanding common stock in the open market through December 31, 2021. Repurchased shares are immediately retired and returned to unissued status. During the nine months ended September 30, 2021, 344,775 shares were repurchased for $1.3 million, inclusive of broker's commissions.

Advertising

The Company charges advertising costs to expense as incurred and such charges are included in sales and marketing expenses in the Consolidated Statements of Operations. The Company's advertising expenses consist primarily of online advertising, search costs, email advertising, and radio advertising. In addition, we reimburse our customers and third parties for in store activities and record these costs as sales and marketing expenses. Advertising costs were $3.0 million and $7.3 million for the three and nine months ended September 30, 2021, respectively, and $1.8 million and $4.4 million for the three and nine months ended September 30, 2020, respectively.

Table of Contents

New ~~Accounting Standards~~accounting standards

Recently adopted

ASU 2020-03 “Codification Improvements to Financial Instruments”

In March 2020, FASB issued Accounting Standards Update ("ASU") 2020-03, Codification Improvement to Financial Instruments. This ASU improves and clarifies various financial instruments topics, including the current expected credit losses standard issued in 2016. The ASU includes seven different issues that describe the areas of improvement and the related amendments to GAAP, intended to make the standards easier to understand and apply by eliminating inconsistencies and providing clarifications. The amendments have different effective dates, some of which were effective for the Company beginning on January 1, 2021. The amendments adopted did not have a material impact on the Company’s condensed consolidated financial statements.

ASU 2019-12 “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes”

In December 2019, the FASB issued ASU No. 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes” (“ASU 2019-12”), which is intended to simplify various aspects related to accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. This new guidance was effective for the Company beginning on January 1, 2021 and did not have an impact on the Company’s condensed consolidated financial statements.

Issued but not yet adopted

ASU 2016-13 “Financial Instruments – Credit Losses (Topic 326)”

In June 2016, the FASB issued ASU 2016-13 “Financial Instruments - Credit Losses (Topic 326),” a new standard to replace the incurred loss impairment methodology under current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The standard is effective for the Company on January 1, 2023, and early adoption is permitted. The Company is currently evaluating the impact the ~~new~~ standard will have on its consolidated financial ~~statements.~~statements and related disclosures.

ASU 2020-04 “Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting”

In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. This ASU provides optional expedient and exceptions for applying generally accepted accounting principles to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. In response to the concerns about structural risks of interbank offered rates (IBORs) and, particularly, the risk of cessation of the London Interbank Offered Rate (LIBOR), regulators in several jurisdictions around the world have undertaken reference rate reform initiatives to identify alternative reference rates that are more observable or transaction based and less susceptible to manipulation. The ASU provides companies with optional guidance to ease the potential accounting burden associated with transitioning away from reference rates that are expected to be discontinued. The ASU can be adopted no later than December 1, 2022 with early adoption permitted. The Company is currently evaluating the impact the standard will have on its consolidated financial statements and related disclosures.

~~Table of Contents~~

ASU 2020-06 "Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40), Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity

In August 2020, FASB issued ASU 2020-06, Debt - Debt with Conversion and other Options (Subtopic 470-20) and Derivatives and Hedging - Accounting for Convertible Instruments and Contracts in an Entity's Own Equity. This ASU reduces the number of accounting models for convertible instruments, amends diluted EPS calculations for convertible instruments, and amends the requirements for a contract (or embedded derivative) that is potentially settled in an entity’s own shares to be classified in equity. This standard is effective for the Company beginning on January 1, 2024 with early adoption permitted. The Company is currently evaluating the impact of this standard on its consolidated financial statements and related disclosures.

Note 2 - Revenue

The Company records revenue net of discounts, which primarily consist of early pay discounts, general percentage allowances and contractual trade promotions.

The Company excludes sales taxes collected from revenues. Retail-partner based customers are not subject to sales tax.

The Company’s direct-to-consumer ("DTC") loyalty program enables customers to accumulate points based on their spending. A portion of revenue is deferred at the time of sale when points are earned and recognized when the loyalty points are redeemed. ~~As of March 31, 2021 and December 31, 2020, customers held unredeemed loyalty program awards of $0.3 million and $0.4 million, respectively.~~

Shipping ~~Costs~~costs

Shipping costs associated with moving finished products to customers were ~~$0.5~~$1.2 million and $1.1 million for the nine months ended September 30, 2021 and 2020, respectively, and $0.3 million and $0.4 million for the three months ended ~~March 31,~~September 30, 2021 and 2020, respectively. Such shipping costs are recorded as part of general and administrative expenses.

Table of Contents

Revenue ~~Channels~~channels

The Company groups its revenue channels into four distinct categories: E-Commerce, which includes the sale of product to online retailers such as Amazon and Chewy; Brick & Mortar, which includes the sale of product to pet specialty chains such as Petco, PetSmart, select grocery chains, and neighborhood pet stores; DTC, which includes the sale of product through the Company's online web platform to more than 20,000 unique customers; and International, which includes the sale of product to foreign distribution partners ~~(transacted in U.S. dollars)~~ and to select international ~~retailers.~~ retailers (transacted in U.S. dollars).

Information about the Company’s net sales by revenue channel is as follows (in thousands):


		Three Months Ended March 31,									Nine Months Ended September 30,								Three Months Ended September 30,
		2021				2020					2021				2020				2021				2020
E-commerce	E-commerce	$	4,010	37	%	$	4,481	37	%	E-commerce	$	11,644	33	%	$	10,969	33	%	$	4,742	36	%	$	3,510	32	%
Brick & Mortar	Brick & Mortar	1,894		18	%	2,897		23	%	Brick & Mortar	5,408		16	%	6,725		20	%	1,816		14	%	1,953		17	%
DTC	DTC	2,436		22	%	2,804		23	%	DTC	7,140		20	%	8,198		25	%	2,363		18	%	2,672		24	%
International	International	2,490		23	%	2,044		17	%	International	10,827		31	%	7,410		22	%	4,279		32	%	3,000		27	%
Net Sales	Net Sales	$	10,830	100	%	$	12,226	100	%	Net Sales	$	35,019	100	%	$	33,302	100	%	$	13,200	100	%	$	11,135	100	%

Note 3 - Inventories

Inventories are summarized as follows (in thousands):

March 31, 2021 December 31, 2020
Food, treats and supplements $ 4,439 $ 4,987
Inventory packaging and supplies 503 596
Total Inventories 4,942 5,583
Inventory reserve (360) (714)
Inventories, net $ 4,582 $ 4,869


	September 30, 2021		December 31, 2020
Food, treats and supplements	$	3,150	$	4,987
Inventory packaging and supplies	637		596

Total Inventories	3,787		5,583
Inventory reserve	(363)		(714)
Inventories, net	$	3,424	$	4,869

~~Table of Contents~~

Note 4 - Prepaid expenses and other current assets

March 31, 2021 December 31, 2020
Prepaid advertising contract with iHeart (1)
$ 2,500 $ 1,788
Other prepaid expenses and other current assets (2)
1,758 2,286
Total Prepaid expenses and other current assets $ 4,258 $ 4,074
Prepaid expenses and other current assets are summarized as follows (in thousands):


	September 30, 2021		December 31, 2020
Prepaid advertising contract with iHeart (1)	$	2,095	$	1,788
Other prepaid expenses and other current assets (2)	1,631		2,286
Total Prepaid expenses and other current assets	$	3,726	$	4,074

(1) On August 28, 2019, the Company entered into a radio advertising agreement with iHeart Media + Entertainment, Inc. and issued ~~1,000,000~~166,667 shares of common stock valued at $3.4 million for future advertising services. The Company issued an additional ~~125,000~~20,834 shares valued at $0.1 million on March 5, 2020 pursuant to the agreement. The current portion of the remaining value, reflected above, is the remaining value of services that ~~are required~~the Company expects to ~~be utilized~~utilize within the ~~next~~ twelve months following the reporting period date, unless the term is extended. ~~The~~There was a long-term portion of ~~the remaining value of $0.5 million and~~ $1.2 million ~~was~~ recorded in other non-current assets as of ~~March 31, 2021 and~~ December 31, ~~2020, respectively.~~2020.

(2) As of ~~March 31,~~September 30, 2021, this amount includes various other prepaid contracts. ~~During the fourth quarter of~~In December 2020, the Company entered into an agreement for access to an investment platform in exchange for ~~500,000~~83,334 shares of common stock valued at ~~$0.5~~$0.6 million and also entered into an agreement for marketing services in exchange for ~~500,000~~83,334 shares of common stock valued at $0.5 ~~million.~~million, both of which are being amortized over 12 months.

Table of Contents

Note 5 - Accrued and other liabilities

Accrued and other liabilities consist of the following (in thousands):


		March 31, 2021		December 31, 2020			September 30, 2021		December 31, 2020
Accrued professional fees	Accrued professional fees	$	225	$	704	Accrued professional fees	$	197	$	697
Accrued sales tax	Accrued sales tax	412		1,009		Accrued sales tax	136		1,009
Accrued payroll and benefits	Accrued payroll and benefits	1,147		913		Accrued payroll and benefits	939		913
Accrued trade promotions	Accrued trade promotions	112		106		Accrued trade promotions	44		106
Accrued interest	Accrued interest	24		86		Accrued interest	23		86
Deferred revenue						Deferred revenue	182		350
Other	Other	170		185		Other	86		239
Total accrued liabilities		$	2,090	$	3,003
Total accrued and other liabilities						Total accrued and other liabilities	$	1,607	$	3,400

Note 6 - Intangible assets, royalties, and goodwill

Intangible assets

The Company’s intangible assets (in thousands) and related useful lives (in years) are as follows:


					March 31, 2021				December 31, 2020								September 30, 2021				December 31, 2020
		Estimated Useful Life	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Accumulated Amortization		Net Carrying Amount			Estimated useful life	Gross carrying amount		Accumulated amortization		Net carrying amount		Accumulated amortization		Net carrying amount
Customer relationships	Customer relationships	7	$	7,190	$	(1,317)	$	5,873	$	(1,059)	$	6,131	Customer relationships	7	$	7,190	$	(1,831)	$	5,359	$	(1,059)	$	6,131
Trade name	Trade name	15	7,500		(641)		6,859		(516)		6,984		Trade name	15	7,500		(891)		6,609		(516)		6,984
Total intangible assets	Total intangible assets		$	14,690	$	(1,958)	$	12,732	$	(1,575)	$	13,115	Total intangible assets		$	14,690	$	(2,722)	$	11,968	$	(1,575)	$	13,115

Amortization expense was $0.4 million and $1.2 million for both the three and nine months ended ~~March 31,~~September 30, 2021 and 2020, respectively.

The estimated future amortization of intangible assets over the remaining weighted average useful life of ~~10.0~~9.6 years is as follows (in thousands):


Remainder of 2021	Remainder of 2021	$	1,145	Remainder of 2021	$	382
2022	2022	1,527		2022	1,527
2023	2023	1,527		2023	1,527
2024	2024	1,527		2024	1,527
2025	2025	1,527		2025	1,527
Thereafter	Thereafter	5,479		Thereafter	5,478
		$	12,732		$	11,968

There were no indicators or impairment of the intangible assets as of ~~March 31,~~September 30, 2021.

~~Table of Contents~~

Goodwill

Goodwill was $18.6 million as of ~~March 31,~~September 30, 2021 and December 31, 2020, respectfully. The Company performed a quantitative assessment for its annual impairment test as of October 1, 2020. Under the quantitative approach, the Company makes various estimates and assumptions to determine the estimated fair value of the reporting unit using a combination of a discounted cash flow model and earnings multiples for guideline public companies. As of ~~March 31,~~September 30, 2021, there was 0no accumulated impairment loss and 0no impairment expense related to ~~goodwill.~~goodwill and no indicators, events or changes in circumstances that would indicate goodwill was impaired during the period from October 2, 2020 through September 30, 2021.

Table of Contents

Note 7 - Debt

The components of the Company’s debt consist of the following (in thousands):


Dollars in thousands	Dollars in thousands	March 31, 2021					December 31, 2020					Dollars in thousands	September 30, 2021					December 31, 2020
		Amount		Rate		Maturity Date	Amount		Rate		Maturity Date		Amount		Rate		Maturity Date	Amount		Rate		Maturity Date
Term loan, net	Term loan, net	$	5,847	(1)		1/6/2024	$	7,826	(2)		1/15/2021	Term loan, net	$	5,559	(1)		1/6/2024	$	7,826	(2)		1/15/2021
Line of credit, net	Line of credit, net	4,781		(1)		1/6/2024	5,023		(3)		7/5/2022	Line of credit, net	4,846		(1)		1/6/2024	5,023		(3)		7/5/2022
November 2019 notes payable, net (November 2019 Notes)	November 2019 notes payable, net (November 2019 Notes)	2,927		10.00	%	6/30/2023	2,830		10.00	%	6/30/2023	November 2019 notes payable, net (November 2019 Notes)	—		—	%	(4)	2,830		10	%	6/30/2023
December 2019 senior notes payable, net (Senior Seller Notes)	December 2019 senior notes payable, net (Senior Seller Notes)	10,679		10.00	%	6/30/2023	10,332		10.00	%	6/30/2023	December 2019 senior notes payable, net (Senior Seller Notes)	—		—	%	(4)	10,332		10	%	6/30/2023
December 2019 junior notes payable, net (Junior Seller Notes)	December 2019 junior notes payable, net (Junior Seller Notes)	5,153		10.00	%	6/30/2023	4,973		10.00	%	6/30/2023	December 2019 junior notes payable, net (Junior Seller Notes)	—		—	%	(4)	4,973		10	%	6/30/2023
ABG Notes	ABG Notes	702		10.00	%	6/30/2023	687		10.00	%	6/30/2023	ABG Notes	—		—	%	(4)	687		10	%	6/30/2023
June 2020 notes payable, net (June 2020 Notes)	June 2020 notes payable, net (June 2020 Notes)	148		10.00	%	6/30/2023	88		10.00	%	6/30/2023	June 2020 notes payable, net (June 2020 Notes)	—		—	%	(4)	88		10	%	6/30/2023
Halo PPP Loan	Halo PPP Loan	431		1.00	%	5/3/2022	431		1.00	%	5/3/2022	Halo PPP Loan	—		—	%	(4)	431		1	%	5/3/2022
TruPet PPP Loan	TruPet PPP Loan	421		0.98	%	4/6/2022	421		0.98	%	4/6/2022	TruPet PPP Loan	—		—	%	(4)	421		0.98	%	4/6/2022
Total debt	Total debt	31,089					32,611					Total debt	10,405					32,611
Less current portion	Less current portion	943					8,016					Less current portion	780					8,016
Total long term debt	Total long term debt	$	30,146				$	24,595				Total long term debt	$	9,625				$	24,595

(1)Interest at a variable rate of LIBOR plus 250 basis points with an interest rate floor of 2.50% per annum

(2)Interest at Bank of Montreal Prime plus 8.05%

(3)Interest at a variable rate of LIBOR plus 250 basis points with an interest rate floor of 3.25% per annum

(4)Converted to common stock upon commencement of the trading of the Company's common stock on the NYSE on June 29, 2021. See "Note 1 - Nature of business and summary of significant accounting policies" for additional information.

Term loans and lines of credit

On December 19, 2019, the Company entered into a Loan Facilities Agreement (the “Facilities Agreement”) by and among the Company, as the borrower, the several lenders from time to time parties thereto (collectively, the “Lenders”) and a private debt lender, as agent (the “Agent”). The Facilities Agreement provided for (i) a term loan facility of $20.5 million and (ii) a revolving loan facility not to exceed $7.5 million. The term loan balance of $7.8 million at December 31, 2020 was ~~scheduled~~related to ~~mature~~the Company's prior loan facilities agreement and after the fifth amendment to that agreement was entered into on ~~December 19,~~November 25, 2020, ~~or such earlier~~the term loan maturity date ~~on which a demand was made by the Agent or any Lender, and~~ was extended as discussed below. The remaining revolving credit facility balance of $5.1 million was repaid in full with a portion of the proceeds from the ABL Facility, discussed below, and resulted in a loss on debt extinguishment of $0.1 million.

~~Certain directors and shareholders of the Company (“Shareholder Guarantors”) agreed~~ to guarantee the Company’s obligations under the Facilities Agreement up to an aggregate amount of $20.0 million pursuant to a Continuing Guarantee between the Shareholder Guarantors and the lender under the Facilities Agreement (the "Shareholder Guaranties"). As consideration for the Shareholder Guaranties, the Company issued common stock purchase warrants to the Shareholder Guarantors in an amount equal to 0.325 warrants for each dollar of debt guaranteed by such Shareholder Guarantors (the “Guarantor Warrants”).January 15, 2021.

On July 16, 2020, the Company entered into a revolving line of credit with Citizens Business Bank in the aggregate amount of $7.5 million (the “ABL Facility”). The proceeds of the ABL Facility were used (i) to repay all principal, interest and fees outstanding under the Company’s previous revolving credit facility and (ii) for general corporate purposes. Debt issuance costs of less than $0.1 million were incurred related to the Company entering into this revolving line of credit.

~~Table of Contents~~

~~The~~ ABL Facility was scheduled to mature on July 5, 2022 and ~~bore~~accrued interest at a variable rate of LIBOR plus 250 basis points, with an interest rate floor of 3.25% per annum. Accrued interest on the ABL Facility was payable monthly commencing on August 5, 2020. The ABL Agreement provided for customary financial covenants, such as maintaining a specified adjusted EBITDA and a maximum senior debt leverage ratio, that commenced on December 31, 2020 and customary events of default, including, among others, those relating to failure to make payment, bankruptcy, breaches of representations and material adverse effects. The ~~Company prepaid all of the outstanding principal under the ABL Facility in full and did not incur any prepayment charges.~~

~~The~~ ABL Facility was secured by a general security interest on the assets of the Company and was personally guaranteed by a member of the Company’s board of directors.

~~On October 5, 2020,~~ The Company prepaid all the ~~Company paid down~~outstanding principal and accrued interest under the term loan by $11.0 million using proceeds from the Series F Private Placement. On October 29, 2020, the Company made an additional pay down on the term loan of $1.0 million using additional proceeds from the Series F Private Placement.

~~On November 25, 2020, the Company entered into the fifth amendment to the Facilities Agreement, extending the maturity date of the term loan to January 15, 2021.~~ABL Facility in full and did not incur any prepayment charges.

On January 6, 2021, Halo, Purely for Pets, Inc., a wholly owned subsidiary of Better Choice Company Inc. ("Halo") entered into a credit facility with Old Plank Trail Community Bank, N.A., an affiliate of Wintrust Bank, N.A. (“Wintrust”) consisting of a $6.0 million term loan and a $6.0 million revolving line of credit, each scheduled to mature on January 6, 2024 and each bear interest at a variable rate of LIBOR plus 250 basis points, with an interest rate floor of 2.50% per annum (the "Wintrust Credit Facility"). Accrued interest on the Wintrust Credit Facility is payable monthly commencing on February 1, 2021. Principal payments are required to be made monthly on the term loan commencing February 2021 with a balloon payment upon maturity. The proceeds from the Wintrust Credit Facility were used (i) to repay ~~the~~outstanding principal, interest and fees ~~outstanding~~ under the ABL Facility and (ii) for general corporate purposes. WeThe Company applied extinguishment accounting to the outstanding balances of the term loan and ABL Facility ~~and term loan~~ and recorded a loss on extinguishment of debt of $0.4 million during the three months ended March 31, 2021. Debt issuance costs of $0.1 million were incurred related to the Wintrust Credit Facility.

Table of Contents

The Wintrust Credit Facility subjects the Company to certain financial covenants, including the maintenance of a fixed charge coverage ratio of no less than 1.25 to 1.00, tested as of the last day of each fiscal quarter. The numerator in the fixed charge coverage ratio is the operating cash flow of Halo, defined as Halo EBITDA less cash paid for unfinanced Halo capital expenditures, income taxes and dividends. The denominator is fixed charges such as interest expense and principal payments paid or payable on other indebtedness attributable to Halo.

The Wintrust Credit Facility is secured by a general guaranty and security interest on the assets, including the intellectual property, of the Company and its subsidiaries. The Company has also pledged all of the capital stock of Halo held by the Company as additional collateral. Furthermore, the Wintrust Credit Facility iswas supported by a collateral pledge by a member of the Company’s board of ~~directors.~~directors; as a result of the Wintrust Amendment described below, this collateral pledge was terminated and released.

On August 13, 2021, Halo entered into the first amendment to the Wintrust Credit Facility (the “Wintrust Amendment”) to increase the revolving line of credit from $6.0 million to $7.5 million. The Wintrust Amendment also required Halo to secure the credit facility with a pledge of a deposit account in the amount of $7.2 million, which decreases to $6.9 million on January 1, 2022 and to $6.0 million on January 1, 2023.

As of ~~March 31,~~September 30, 2021, the term loan and line of credit outstanding under the Wintrust Credit Facility were ~~$5.8~~$5.6 million and $4.8 million, respectively, net of debt issuance costs of less than $0.1 million, respectively. As of December 31, 2020, the previous term loan and line of credit outstanding were $7.8 million and $5.0 million, respectively, net of debt issuance costs and discounts of less than $0.2 million and $0.2 million, respectively. ~~The debt~~Debt issuance costs and discounts are amortized using the effective interest method.

~~As of March 31, 2021 and December 31, 2020, the Company was in compliance with its debt covenants.~~

Notes payable

On November 4, 2019, the Company issued $2.8 million of subordinated convertible notes (the “November 2019 Notes”) which ~~carry~~carried a 10% interest rate and ~~mature on~~a maturity date of November 4, 2021. The interest iswas payable in kind, in arrears on March 31, June 30, September 30 and December 31 of each year. Payment in kind ("PIK") interest iswas payable by increasing the aggregate principal amount of the November 2019 Notes. The November 2019 Notes ~~are~~were convertible any time from the date of issuance and carried an initial conversion price of the lower of (a) ~~$4.00~~$24.00 per share or (b) the IPO ~~Price (defined as the price at which the Company’s stock will be sold in a future IPO).~~

Price. The November 2019 Notes were amended on January 6, 2020. The amendment ~~incorporates~~incorporated only the preferable terms of the Seller Notes as noted below, and all other terms and provisions of the November 2019 Notes ~~remain~~remained in full force and effect. As amended, for so long as any event of default ~~(as defined in the November 2019 Notes) exists,~~existed and was continuing, interest ~~shall~~would accrue ~~on the November 2019 Notes principal~~ at the default interest rate of 12.0% per annum, and such accrued interest ~~shall~~would be immediately due and payable.

~~Table of Contents~~

The November 2019 Notes were amended for the second time on June 24, 2020 in connection with the issuance of the June 2020 Notes. The amendment lowers the maximum conversion price applicable to the conversion of these notes from $4.00 per share to $3.75 per share and extends the maturity date from November 4, 2021 to June 30, 2023. Under the applicable accounting guidance, the Company accounted for the change in conversion price as a modification of the debt instrument. The Company recognized the increase in the fair value of the conversion option of $0.3 million as a reduction to the carrying amount of the debt instrument by increasing the associated debt discount with a corresponding increase in additional paid-in capital.

As of March 31, 2021 and December 31, 2020, the November 2019 Notes outstanding were $2.9 million and $2.8 million, respectively, net of discounts of $0.2 million and less than $0.3 million, respectively. The discounts are being amortized over the life of the November 2019 Notes using the effective interest method.

On December 19, 2019, the Company issued $10.0 million and $5.0 million in senior subordinated convertible notes (the “Senior Seller Notes”) and junior subordinated convertible notes (the “Junior Seller Notes” and together with the Senior Seller Notes, the “Seller Notes”), respectively, to the sellers of Halo. The Seller Notes ~~are~~were convertible any time from the date of issuance and ~~carry~~carried a 10% interest rate and ~~mature on~~a maturity date of June 30, 2023. Interest iswas payable in kind, in arrears on March 31, June 30, September 30 and December 31 of each ~~year. PIK interest is payable~~year by increasing the aggregate principal amount of the Seller Notes. The Seller Notes carried a conversion price of the lower of (a) ~~$4.00~~$24.00 per share or (b) the IPO Price.

The Seller Notes were amended on June 24, 2020 in connection with the issuance of the June 2020 Notes. The amendment lowers the maximum conversion price applicable to the conversion of these notes from $4.00 per share to $3.75 per share. The Company accounted for the change in the conversion price as a modification of the debt instrument. The Company recognized the increase in the fair value of the conversion option of less than of $0.3 million as a reduction to the carrying amounts of the debt instruments by increasing the associated debt discounts with a corresponding increase in additional paid-in capital.

As of March 31, 2021, the Senior Seller Notes outstanding were $10.7 million, net of discounts of $0.7 million, and the Junior Seller Notes outstanding were $5.2 million, net of discounts of $0.5 million. As of December 31, 2020, the Senior Seller Notes outstanding were $10.3 million, net of discounts of $0.8 million, and the Junior Seller Notes outstanding were $5.0 million, net of discounts of $0.5 million. The discounts are being amortized over the life of the Seller Notes using the effective interest method.

On January 13, 2020, the Company issued $0.6 million in senior subordinated convertible notes to Authentic Brands and Elvis Presley Enterprises (“ABG”) in connection with the termination of a previous licensing agreement (the "ABG Notes"). The terms of the ABG Notes ~~match those of~~were the same as the Seller Notes, including conversion features convertible any time after the date of issuance, a 10% interest rate and maturity date of June 30, 2023. The interest is payable in kind, in arrears on March 31, June 30, September 30 and December 31 of each year. PIK interest is payable by increasing the aggregate principal amount of the ABG Notes. ~~The ABG Notes carried an initial conversion price of the lower of (a) $4.00 per share or (b) the IPO Price.~~

In addition to issuing the ABG Notes, as part of the ABG termination on January 13, 2020, the Company paid ABG $0.1 million in cash, issued ABG ~~72,720~~12,120 shares of the Company’s common stock, agreed to pay ABG $0.1 million in cash in four equal installments each month from July 31, 2020 through October 31, 2020 and issued ABG common stock purchase warrants (the “ABG Warrants”) equal to a fair value of $0.2 million.

The November 2019 Notes were amended for the second time and the Seller Notes and the ABG Notes were also amended on June 24, 2020 in connection with the issuance of the June 2020 ~~Notes.~~Notes, discussed below. The ~~amendment lowers~~amendments lowered the maximum conversion price applicable to the conversion of these notes from ~~$4.00~~$24.00 per share to ~~$3.75~~$22.50 per ~~share.~~share and aligned all maturity dates to be June 30, 2023. The Company accounted for the change in ~~the~~ conversion price as a modification of the debt ~~instrument. The Company~~instruments and recognized the increase in the fair value of the conversion option ~~of less than $0.1 million~~ as a reduction to the carrying amount of the respective debt instrument by increasing the associated debt discount or decreasing the ~~associated~~ debt premium, with a corresponding increase in ~~additional~~Additional paid-in capital.

As The increase in fair value of ~~March 31, 2021~~the conversion options were $0.3 million for the November 2019 Notes, less than $0.3 million for the Seller Notes and ~~December 31, 2020, the ABG Notes outstanding were $0.7 million, including a debt premium of~~ less than $0.1 million ~~respectively. The debt premium is being amortized over the life of~~for the ABG ~~Notes using the effective interest method.~~Notes.

On June 24, 2020, the Company issued $1.5 million in subordinated convertible promissory notes (the “June 2020 Notes”) which ~~carry~~carried a 10% interest rate and ~~mature~~matures on June 30, 2023. ~~The interest is~~Interest was payable ~~quarterly~~ in kind, in arrears on March 31, June 30, September 30, and December 31 of each ~~year. PIK interest is payable~~year by increasing the aggregate principal amount of the June 2020 Notes. The June 2020 Notes ~~are~~were convertible any time from the date of issuance and ~~carry~~carried a conversion price ~~$0.75~~$4.50 per share. ~~The June 2020 Notes are also convertible automatically upon the Company’s consummation of an initial public offering or change in control (each as defined in the June 2020 Notes).~~

1415

Table of Contents

The Company evaluated the conversion option within the June 2020 Notes to determine whether the conversion price was beneficial to the note ~~holders. The Company~~holders and recorded a beneficial conversion feature (“BCF”) related to the issuance of ~~the June 2020 Notes.~~these notes. The BCF for the June 2020 Notes was recognized and measured by allocating a portion of the proceeds to the ~~beneficial conversion feature,~~BCF, based on relative fair value, and as a reduction to the carrying amount of the convertible instrument equal to the intrinsic value of the conversion feature limited to the proceeds amount allocated to the instrument. The discount recorded in connection with the BCF valuation iswas being accreted as interest expense over the term of the June 2020 Notes, using the effective interest rate method. Upon the conversion of the June 2020 Notes discussed below, the remaining discount of $1.4 million associated with the June 2020 Notes was fully accreted through interest expense.

As of ~~March 31,~~September 30, 2021, all of the notes payable described had $0 outstanding since they were automatically converted to common stock in connection with the Company's IPO, at a price of $5.00 per share (except for the June 2020 Notes, which were converted at a price of $4.50 per share). See "Note 1 - Nature of business and summary of significant accounting policies" for additional information. As of December 31, 2020, the November 2019 Notes outstanding were $2.8 million, net of discounts of less than $0.3 million, the Senior Seller Notes outstanding were $10.3 million, net of discounts of $0.8 million, the Junior Seller Notes outstanding were $5.0 million, net of discounts of $0.5 million, the ABG Notes outstanding were $0.7 million, including a debt premium of less than $0.1 million, and the June 2020 Notes outstanding were less than $0.1 million, net of discounts of less than $1.5 ~~million, respectively.~~million. The debt discounts ~~are~~and premium were being amortized over the life of the ~~June 2020 Notes~~respective notes using the effective interest method.

The exercise, conversion or exchange of convertible securities, including for other securities, will dilute the percentage ownership of the Company’s stockholders. The dilutive effect of the exercise or conversion of these securities may adversely affect the Company’s ability to obtain additional capital.

~~The Company previously issued~~Previously, $0.1 million of the Seller Notes towere held by an executive ~~in satisfaction~~ of ~~a transaction bonus pursuant to his employment agreement. These convertible notes remained outstanding as of March 31, 2021 and December 31, 2020. Additionally,~~ the Company ~~previously issued~~and $2.2 million of the subordinated convertible notes towere held by a member of the board of directors, all of which ~~remain outstanding~~were converted to common stock as ~~of March 31,~~described above. PIK interest related to these notes was $0.1 million for the nine months ended September 30, 2021 and ~~December 31, 2020. Interest expense related to the subordinated convertible notes was~~ less than $0.1 million and $0.1 million for the three and nine months ended ~~March 31, 2021 and~~September 30, 2020, respectively.

As of March 31, 2021 and December 31, 2020, the Company was in compliance with all covenant requirements and there were no events of default. All notes payable are subordinated to the term loan and line of credit.

PPP loans

On April 10, 2020, TruPet, LLC, a wholly owned subsidiary of Better Choice Company Inc., was granted a loan from JPMorgan Chase Bank, N.A. in the aggregate amount of $0.4 million, pursuant to the Paycheck Protection Program ("PPP") under Division A, Title I of the CARES Act (the “TruPet PPP Loan”). The loan ~~matures~~matured on April 6, 2022 and ~~bears~~had an interest ~~at a~~ rate of 0.98% per annum, with interest and principal payable monthly, commencing on November 6, 2020. ~~As of March 31,~~During the nine months ended September 30, 2021, ~~and December 31, 2020,~~ the TruPet PPP ~~Loan outstanding~~loan was fully forgiven and the Company recognized a gain on extinguishment of debt of $0.4 million.

On May 7, 2020, Halo, Purely for Pets, Inc., a wholly owned subsidiary of Better Choice Company Inc., was granted a loan from Wells Fargo Bank, N.A. in the aggregate amount of $0.4 million, pursuant to the PPP (the “Halo PPP Loan”). The loan ~~matures~~matured on May 3, 2022 and ~~bears~~had an interest ~~at a~~ rate of 1.00% per annum, with interest and principal payable monthly, commencing on November 1, 2020. ~~As of March 31,~~During the nine months ended September 30, 2021 ~~and December 31, 2020,~~ the Halo PPP ~~Loan outstanding~~loan was ~~$0.4 million.~~

~~Under the terms of the PPP, certain amounts of the loans may be~~fully forgiven ~~if they are used for qualifying expenses as described in the CARES Act. The Company has used all of the proceeds from the TruPet PPP Loan~~ and the ~~Halo PPP Loan for qualifying expenses and during April 2021, the~~ Company ~~applied for forgiveness for both~~recognized a gain on extinguishment of ~~these loans.~~debt of $0.4 million.

The Company recorded interest expense related to its outstanding indebtedness of ~~$0.8~~$3.1 million and ~~$2.3~~$7.3 million for the nine months ended September 30, 2021 and September 30, 2020, respectively, and $0.1 million and $2.5 million for the three months ended ~~March 31,~~September 30, 2021 and ~~March 31,~~September 30, 2020, respectively. PIK interest relating to notes payable was $1.1 million for the nine months ended September 30, 2021 and $0.5 million and $1.5 million for the three and nine months ended September 30, 2020, respectively.

~~Fair Value~~

The fair value of the November 2019, Senior Seller Notes and Junior Seller Notes, ABG Notes and June 2020 Notes were approximately $2.6 million, $9.5 million, $4.7 million, $0.6 million and $1.3 million, respectively, as of March 31, 2021. Fair value was determined by applying the income approach using a discounted cash flow model which primarily uses unobservable inputs (Level 3).

~~The carrying amounts of the Company's PPP loans approximate fair value due to the short term nature.~~ The carrying amount for the Company’s term loan and line of credit approximate fair value as the instruments have variable interest rates that approximate market rates.

As of September 30, 2021 and December 31, 2020, the Company was in compliance with all debt covenant requirements and there were no events of default.

Note 8 - Commitments and contingencies

The Company had 0no material purchase obligations as of ~~March 31,~~September 30, 2021 or December 31, 2020.

~~Table of Contents~~

The Company may be involved in legal proceedings, claims, and regulatory, tax, or government inquiries and investigations that arise in the ordinary course of business resulting in loss contingencies. ~~We accrue~~The Company accrues for loss contingencies when losses become probable and are reasonably estimable. If the reasonable estimate of the loss is a range and no amount within the range is a better estimate, the minimum amount of the range is recorded as a liability. Legal costs such as outside counsel fees and expenses are charged to expense in the period incurred and are recorded in general and administrative expenses in the ~~condensed consolidated statements~~Condensed Consolidated Statements of ~~operations and comprehensive loss. We do~~Operations. The Company does not accrue for contingent losses that are considered to be reasonably possible, but not probable; however, ~~we disclose~~the Company discloses the range of such reasonably possible losses. Loss contingencies considered remote are generally not disclosed.

Table of Contents

Litigation is subject to numerous uncertainties and the outcome of individual claims and contingencies is not predictable. It is possible that some legal matters for which reserves have or have not been established could result in an unfavorable outcome for the Company and any such unfavorable outcome could be of a material nature or have a material adverse effect on the Company's consolidated financial condition, results of operations and cash flows. Management is not aware of any claims or lawsuits that may have a material adverse effect on the consolidated financial position or results of operations of the Company.

Note 9 - Convertible preferred stock

During October, 2020, the Company consummated an insider-led equity financing, including the transactions contemplated by a securities purchase agreement (the “Securities Purchase Agreement”) between the Company and certain accredited and sophisticated investors (the “Purchasers”) and an exchange agreement (the “Series E Exchange Agreement”) between the Company and Cavalry Fund LP ("Cavalry"), the holder of all of the Company’s previously outstanding Series E preferred stock.

Pursuant to the Securities Purchase Agreement, the Company, in a private placement (the “Series F Private Placement”), issued and sold units (the “Series F Units”) to the Purchasers for a purchase price of $1,000 per Unit. Each Unit ~~consists~~consisted of: (i) 1 share of the Company’s Series F convertible preferred stock, par value $0.001 per share (the “Series F Preferred Stock”), which is convertible into shares of the Company’s common stock, par value $0.001 per share, at a value per share of common stock of ~~$0.50;~~$3.00; and (ii) a warrant to purchase for a six year period such number of shares of common stock (the “Series F Warrant Shares”) into which such share of Series F Preferred Stock is convertible at an exercise price per Warrant Share of ~~$0.75.~~$4.50. Pursuant to the Series F Private Placement, the Company raised approximately $18.2 million in gross cash proceeds, approximately $6.5 million of which was invested by certain officers, directors, employees and associated related parties thereto of the Company. The Series F Shares were recorded at fair value on the date of issuance on an as converted basis.

Concurrently with the execution of the Securities Purchase Agreement, the Company and the Purchasers entered into a registration rights agreement, (as amended by a certain first amendment dated October ~~29,2020,~~29, 2020, the "Registration Rights Agreement"), pursuant to which the Company filed a registration statement which was declared effective by the SEC on February 16, 2021 to register the Warrant Shares and the shares of common stock issuable upon conversion of the Series F Preferred Stock.

In connection with the consummation of the Series F Private Placement, on October 1, 2020, the Company filed with the Secretary of State of Delaware a Certificate of Designations which authorizes a total of 30,000 shares of Series F Preferred Stock and sets forth the designations, preferences, and rights of the Company's Series F Preferred Stock.

On October 1, 2020, the Company issued 14,264 Series F Units in ~~conjunction~~connection with ~~money received for~~ the Series F Private Placement. In addition, pursuant to the Series E Exchange Agreement, on October 1, 2020, the Company issued 3,500 Series F Units to Cavalry in exchange for all of its outstanding Series E Preferred Stock. The exchange of Series E Preferred Shares resulted in a $5.4 million gain and was recorded to Accumulated deficit on the Company's Condensed Consolidated Balance Sheets.

On October 12, 2020 and October 23, 2020, the Company issued 1,106 and 2,832 Series F Units, respectively, in ~~conjunction~~connection with the Series F Private Placement. In addition, on October 23, 2020, the Company issued an additional 100 shares of Series F Preferred Stock in conjunction with a marketing agreement.

The Company evaluated the conversion option within the Series F Preferred Stock on the dates of issuance to determine whether the conversion price was beneficial to the holders. The Company recorded a BCF related to the issuance of the Series F Preferred Stock. The BCF was recognized and measured by allocating a portion of the proceeds to the beneficial conversion feature, based on fair value and was recorded to Accumulated deficit on the Company's Condensed Consolidated Balance Sheets limited to the proceeds amount allocated to the instrument.

~~Table~~On July 1, 2021, all outstanding shares of ~~Contents~~

~~The rights, preferences and privileges of Series F are as follows:~~

~~Ranking~~

~~Except~~convertible preferred stock were converted to common stock in connection with the ~~extent the holders~~consummation of the ~~Series F Preferred Stock consent to the creation~~Company's IPO. See "Note 1 - Nature of ~~a class~~business and summary of equity securities ranking senior to, or pari passu with, the Series F Preferred Stock, the Series F Preferred Stock shall rank senior to all shares of capital stock of the Company with respect to preferences as to dividends, distributions and payments upon liquidation, dissolution or winding up of the Company.significant accounting policies" for additional information.

~~Voting~~

As to matters submitted to the holders of the Common Stock, each holder of the Series F Preferred Stock will be entitled to such number of votes equal to the number of shares of Common stock issuable upon conversion of such holder’s Series F Preferred Stock and shall vote, or provide consent, together with the Common Stock as if they were a single class. The holders of the Series F Preferred Stock shall vote as a separate class on matter affecting the terms of the Series F Preferred Stock, such as the authorization of a class of equity securities ranking senior to, or pari passu with, the Series F Preferred Stock.

~~Dividends~~

Holders of Series F Preferred Stock will not be entitled to receive dividends except to the extent that dividends are declared on the Series F Preferred Stock by the Company in its sole discretion or declared and made by the Company to holders of the Common Stock. In addition, if the Company grants, issues or sells any options, convertible securities or rights to purchase stock, warrants, securities or other property pro rata to all or substantially all of the record holders of any class of Common Stock (the “Purchase Rights”), then each holder of Series F Preferred Stock will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which such holder could have acquired if such holder had held the number of shares of Common Stock acquirable upon complete conversion of all the Series F Preferred Stock (without taking into account any limitations or restrictions on the convertibility of the Series F Preferred Stock) held by such holder.

~~Liquidation~~

If the Company voluntarily or involuntarily liquidates, dissolves or winds up, the holders of Series F Preferred Stock shall be entitled to receive in cash out of the assets of the Company, whether from capital or from earnings available for distribution to its stockholders, before any amount shall be paid to the holders of any of shares of Common Stock or other capital stock of the Company ranking junior to the Series F Preferred Stock, an amount per share of Series F Preferred Stock equal to the sum of $1,000 (subject to adjustment for stock splits, stock dividends, recapitalizations, reorganizations, reclassifications, combinations, subdivisions or other similar events occurring after the initial issuance date with respect to the Series F Preferred Stock, the “Stated Value”)) plus any accrued and unpaid dividends and late charges (such sum, the “Conversion Amount”). The rights of holders of Series F Preferred Stock to receive their liquidation preference also will be subject to the proportionate rights of capital stock, if any, ranking senior to or in parity with the Series F Preferred Stock as to liquidation.

~~Optional Conversion~~

Subject to certain beneficial ownership limitations contained in the Certificate of Designations, holders of the Series F Preferred Stock shall be entitled to convert each share of outstanding Series F Preferred Stock held by such holder into such number of validly issued, fully paid and non-assessable shares of Common Stock equal to the Conversion Amount of such share of Series F Preferred Stock divided by $0.50 (subject to adjustment, the “Conversion Price”).

~~Automatic Conversion~~

Each share of Series F Preferred Stock not previously converted into shares of Common Stock shall automatically, without any further action by the holders of such Series F Preferred Stock, be converted into such number of fully paid and non-assessable shares of Common Stock determined by dividing the Stated Value of such share of Series F Preferred Stock by the then applicable Conversion Price upon the closing of a firm commitment underwritten public offering of shares of Common Stock which results in the Common Stock being traded on any of The New York Stock Exchange, the NYSE American, the Nasdaq Global Select Market, the Nasdaq Global Market or any successor market thereto. Any such conversion shall be subject to the beneficial ownership limitations set forth in the Certificate of Designations.

~~Anti-dilution~~

Holders of the Series F Preferred Stock are entitled to a “full rachet” anti-dilution adjustment to the Conversion Price in the event the Company issues, sells or grants any shares of Common Stock (or securities convertible, exercisable or exchangeable for Common Stock) for no consideration or for consideration or purchase price per share (or, in the case of securities convertible, exercisable or exchangeable for Common Stock, with a conversion, exercise or exchange price) less than the Conversion Price then in effect.

~~Table of Contents~~

Note 10 - Stockholders’ ~~deficit~~equity (deficit)

On January 22, 2021, the Company consummated a private placement of common stock units (the “January 2021 Private Placement”) in which the Company raised approximately $4.1 million, including an investment by certain officers, directors, employees and associated related parties thereto of approximately $1.6 million. Each common stock unit was sold at a per unit price of ~~$1.25~~$7.50 and consisted of (i) 1 share of the Company’s common stock, par value $0.001 per share; and (ii) a warrant to purchase 1one share of common stock. The proceeds were used to pay expenses related to the offering and for general corporate purposes. In connection with the January 2021 Private Placement, wethe Company entered into a registration rights agreement (the “January 2021 Registration Rights Agreement”) pursuant to which the Company filed a registration statement that was declared effective by the SEC on February 16, 2021 to register the shares of common stock issued, and issuable upon the exercise of the warrants issued, in the January 2021 Private Placement.

Table of Contents

See "Note 1 - Nature of business and summary of significant accounting policies" for additional information regarding the impacts to the Company's Stockholders’ equity (deficit) related to the commencement of its common stock trading on the NYSE and the consummation of its IPO.

The Company has reserved common stock for future issuance as follows:


		March 31, 2021	December 31, 2020		September 30, 2021	December 31, 2020
Conversion of Series F Preferred Stock	Conversion of Series F Preferred Stock	34,611,100	43,507,130	Conversion of Series F Preferred Stock	—	7,251,189
Exercise of options to purchase common stock	Exercise of options to purchase common stock	13,150,872	7,815,442	Exercise of options to purchase common stock	2,672,937	1,302,574
Exercise of warrants to purchase common stock	Exercise of warrants to purchase common stock	60,874,177	59,501,978	Exercise of warrants to purchase common stock	9,433,584	9,916,997
Conversion of Notes payable		7,718,488	7,530,232
Conversion of notes payable				Conversion of notes payable	—	1,255,039
Total	Total	116,354,637	118,354,782	Total	12,106,521	19,725,799

Note 11 - Warrants

The following summarizes the Company's outstanding warrants to purchase shares of the Company's common stock as of and for the periods ~~ending March 31,~~ended September 30, 2021 and December 31, 2020:


		Warrants	Exercise Price			Warrants	Exercise Price
Warrants outstanding as of December 31, 2019	Warrants outstanding as of December 31, 2019	16,981,854	$	3.23	Warrants outstanding as of December 31, 2019	2,830,309	$	19.38
Issued	Issued	49,928,469	$	0.77	Issued	8,321,412	$	4.62
Exercised	Exercised	(1,937,690)	$	0.58	Exercised	(322,948)	$	3.48
Terminated/Expired	Terminated/Expired	(5,470,655)	$	3.07	Terminated/Expired	(911,776)	$	18.42
Warrants outstanding as of December 31, 2020	Warrants outstanding as of December 31, 2020	59,501,978	$	1.22	Warrants outstanding as of December 31, 2020	9,916,997	$	7.32
Issued	Issued	3,288,400	$	1.45	Issued	548,110	$	8.70
Exercised	Exercised	(1,839,275)	$	0.76	Exercised	(389,881)	$	4.52
Terminated/Expired	Terminated/Expired	(76,926)	$	0.65	Terminated/Expired	(641,642)	$	24.64
Warrants outstanding as of March 31, 2021		60,874,177	$	1.18
Warrants outstanding as of September 30, 2021					Warrants outstanding as of September 30, 2021	9,433,584	$	5.92

The intrinsic value of outstanding warrants was ~~$31.3~~$0.0 million and $23.8 million as of ~~March 31,~~September 30, 2021 and December 31, 2020, respectively. The following discussion provides details on the various types of outstanding warrants and the related relevant disclosures around each type.

Warrant ~~Derivative Liability~~derivative liability

During May 2019, the Company acquired ~~712,823~~118,804 warrants with a weighted average exercise price of ~~$3.90~~$23.40 (the "May Acquisitions Warrants"). These warrants included an option to settle in cash in the event of a change of control of the Company and a reset feature if the Company issues shares of common stock with a strike price below the exercise price of the warrants, which required the Company to record the warrants as a derivative liability. The Company calculates the fair value of the derivative liability through a Monte Carlo Model that values the warrants based upon a probability weighted discounted cash flow model.

During January 2020, the Company issued shares below the exercise price of the May Acquisitions Warrants. As such, the Company issued an additional ~~1,003,232~~167,206 warrants on March 17, 2020 to certain of its warrant holders at an exercise price of ~~$1.62~~$9.72 and modified the exercise price of the existing May Acquisitions Warrants to ~~$1.62.~~$9.72.

During June 2020, the Company issued common stock equivalents below the exercise price of the warrants issued on March 17, 2020. As such, the Company issued an additional ~~1,990,624~~331,771 warrants to certain of its warrant holders at an exercise price of ~~$0.75~~$4.50 and modified the exercise price of the existing warrants to ~~$0.75.~~

~~Table of Contents~~

$4.50.

During September 2020, the Company amended all of these warrants to eliminate certain anti-dilution rights, fix the number of shares of common stock purchasable under each warrant, and set the exercise price thereof at ~~$0.65~~$3.90 per share. As such, the Company issued an additional ~~570,258~~95,043 warrants to certain of its warrant holders at an exercise price of ~~$0.65.~~$3.90.

During the fourth quarter of 2020, holders exercised a total ~~1,687,690~~281,282 warrants for which the Company issued shares of common stock. During December 2020, ~~2,512,321~~418,721 of these warrants expired and an immaterial amount remained outstanding as of December 31, 2020, all of which expired during January 2021.

Table of Contents

The following schedule shows the fair value of the warrant derivative liability as of ~~March 31,~~September 30, 2021 and December 31, 2020, and the change in fair value during the periods ended ~~March 31,~~September 30, 2021 and year ended December 31, 2020 (in thousands):


	Warrant Derivative Liability
Balance as of December 31, 2019	$	2,220
Change in fair value of warrant derivative liability	(2,220)
Balance as of December 31, 2020	$	0—
Change in fair value of warrant derivative liability (1)	0—
Balance as of ~~March 31,~~September 30, 2021	$	0—

(1) All of the May Acquisition Warrants were expired ~~during~~by January 2021.

Series F ~~Warrant Liability~~warrant liability

During October 2020, the Company issued ~~43,403,130~~7,233,855 warrants to purchase common stock in connection with the Series F Private Placement ~~(defined below)~~ with an exercise price of ~~$0.75.~~$4.50 (the "Series F Warrants"). The warrants are exercisable commencing on the date of issuance and expire 72 months after the date of issuance. These warrants ~~include~~included a reset feature if the Company issues common stock, options, or convertible securities with a strike price below the exercise price of the warrants. ~~These~~During the second quarter of 2021, a Series F warrant holder exercised 83,334 warrants, resulting in the Company’s receipt of approximately $0.4 million. Initially, these warrants did not meet the definition of a derivative or the requirements to be considered equity; as such, the Company recorded these as a liability. Due to changes in certain terms of the warrant agreements in connection with the Company's IPO whereby the warrants did meet the requirements to be considered equity, the outstanding Series F warrants were reclassified to equity upon consummation of the IPO on July 1, 2021. See "Note 9 - Convertible preferred stock" for more information on Series F.F and see "Note 1 - Nature of business and summary of significant accounting policies" for additional information on the Company's IPO.

The warrant liability iswas remeasured at fair value each reporting period and ~~represents~~upon the Company's IPO and represented a Level 3 financial instrument. The Company calculates the fair value of the warrant liability through a Monte Carlo Model and a Black Scholes Option Model. The total value of the consideration received in connection with the Series F Private Placement was first allocated to the warrant liability at fair value, with the remainder allocated to the preferred stock, which led to a discount ascribed to the Series F Preferred Stock. Accordingly, the Company recorded a discount of $14.6 million on the Series F Preferred Stock by adjusting ~~Series F~~ Additional ~~Paid-in Capital.~~paid-in capital.

The following schedule shows the fair value of the warrant liability upon issuance, and the change in fair value during the periods ended ~~March 31,~~September 30, 2021 and December 31, 2020 (in thousands):


	Warrant liability
Issuance of Series F warrants	$	14,952
Change in fair value of warrant liability	24,898
Balance as of December 31, 2020	$	39,850
Change in fair value of warrant liability	~~6,483~~ (23,463)
Reclassification of warrant liability to equity	(16,387)
Balance as of ~~March 31,~~September 30, 2021	$	~~46,333~~—

Table of Contents

The following schedule shows the inputs used to measure the fair value of the warrant liability:


Warrant Liability	Warrant Liability	March 31, 2021	December 31, 2020	Warrant Liability	July 1, 2021	December 31, 2020
Stock Price	Stock Price	$1.44	$1.27	Stock Price	$4.19	$7.62
Exercise Price	Exercise Price	$0.75	$0.75	Exercise Price	$4.50	$4.50
Expected remaining term (in years)	Expected remaining term (in years)	5.50 - 5.56	5.75 - 5.81	Expected remaining term (in years)	5.25 - 5.31	5.75 - 5.81
Volatility	Volatility	67.5%	67.5%	Volatility	60.0%	67.5%
Risk-free interest rate	Risk-free interest rate	1.1%	0.5%	Risk-free interest rate	0.94%	0.5%

The valuation of the warrants iswas subject to uncertainty as a result of the unobservable inputs. If the volatility rate or risk-free interest rate were to change, the value of the warrants would be impacted.

~~Table of Contents~~

~~Equity-Classified Warrants~~Equity-classified warrants

On May 6, 2019, the Company issued ~~5,744,991~~957,499 warrants to purchase common stock with an exercise price of ~~$4.25~~$25.50 (the "May 2019 PIPE Warrants"). Additionally, in connection with the May 2019 PIPE transaction, the Company issued ~~220,539~~36,757 warrants to brokers with an exercise price of ~~$3.00.~~$18.00. The warrants were exercisable commencing on the issuance date and expire 24 months after the ~~date of issuance.~~issuance date. In March 2021, the Company offered to a limited number of holders the opportunity to exercise, in full or in part, these warrants to purchase shares of Common Stock at a reduced exercise price of ~~$1.25~~$7.50 per share. The Company received exercise notices for a total of ~~1,047,609~~174,602 warrants, resulting in the Company’s receipt of approximately $1.3 million. The Company recognized the increase in the fair value of the modified warrants on the date of exercise of $0.2 million as a deemed dividend through ~~accumulated~~Accumulated deficit with a corresponding increase in ~~additional~~Additional paid-in capital. The remainder of the outstanding and unexercised May 2019 PIPE Warrants expired during May 2021.

On November 4, 2019, the Company issued ~~11,000~~1,834 warrants in connection with the November 2019 Notes. The warrants are exercisable commencing on the date of issuance and expire 24 months from the date of the consummation of ~~a future IPO.~~an IPO, which occurred July 1, 2021. The warrants carried an initial exercise price equal to the greater of (i) ~~$5.00~~$30.00 per share or (ii) the price at which the common stock ~~of the Company~~ was sold in the ~~IPO.~~IPO (which was $5.00).

On December 19, 2019, the Company issued ~~6,500,000~~1,083,334 warrants with an exercise price of ~~$1.82 in conjunction with~~$10.92 as consideration for certain directors and shareholders of the ~~term loan~~Company guaranteeing the Company's obligations under a prior credit facility agreement (the "Guarantor Warrants"), which are exercisable commencing on the date of issuance and expire 24 months from the date of the consummation of ~~a future IPO.~~an IPO, which occurred July 1, 2021. The Guarantor Warrants had a fair value of $4.2 million on the date of issuance.

On December 19, 2019, the Company issued ~~937,500~~156,250 warrants in connection with the Seller Notes. The warrants are exercisable commencing on the date of issuance and expire 24 months from the date of the consummation of ~~a future IPO.~~an IPO, which occurred July 1, 2021. The warrants carried an initial exercise price equal to the greater of (i) ~~$5.00~~$30.00 per share or (ii) the price at which the common stock ~~of the Company~~ was sold in the ~~IPO.~~IPO (which was $5.00).

On January 13, 2020, the Company issued the ABG Warrants, which are exercisable commencing on the date of issuance and expire 24 months from the date of the consummation of an IPO, ~~(as defined in the ABG Warrants)~~which occurred July 1, 2021 and carried an initial exercise price equal to the greater of (i) ~~$5.00~~$30.00 per share or (ii) the price at which the common stock was sold in the ~~IPO.~~IPO (which was $5.00).

On June 24, 2020, the warrants related to the November 2019 Notes, the Seller Notes and the ABG Notes were amended in connection with the issuance of the June 2020 Notes to lower the maximum exercise price applicable to these warrants from ~~$5.00~~$30.00 to ~~$4.25~~$25.50 per share. The decrease in the exercise price resulted in an increase to the fair value of the warrants of $0.1 million which ~~the Company~~was recognized in general and administrative expense.

On June 24, 2020, the Company issued ~~1,000,000~~166,667 warrants to a member of the board of directors with an exercise price of ~~$1.25~~$7.50 per share in connection with the June 2020 Notes (the “June 2020 Warrants”), which are exercisable commencing on the date of issuance and expire ~~on the earlier of (i)~~ 84 months from the date of the consummation of an ~~underwritten public offering or other up-list transaction or (ii) June 30, 2030.~~IPO, which occurred July 1, 2021.

On July 20, 2020, the Company issued ~~300,000~~50,000 warrants to a member of the board of directors with an exercise price of ~~$1.05~~$6.30 per share in consideration for a personal guarantee by a member of the Company's board of directors on the ABL Facility (the "July 2020 Guarantor Warrants"), which are exercisable commencing on the date of issuance and expire ~~on the earlier of (i)~~ 84 months from the date of the consummation of an ~~underwritten public offering or other up-list transaction or (ii) June 30, 2030.~~IPO, which occurred July 1, 2021.

Table of Contents

On January 22, 2021, the Company issued ~~3,288,400~~548,067 warrants in connection with the January 2021 PIPE transaction. The warrants are exercisable at an exercise price per share of ~~$1.45~~$8.70 commencing on the date of issuance and expire after a six year period, subject to beneficial ownership limitations (the “January 2021 Warrants”). Due to the discounted warrant exercise associated with the May 2019 PIPE warrants as discussed above, the down round provision on the January 2021 Warrants was triggered such that these warrants could be exercised at a price of ~~$1.25~~$7.50 per share. The Company recognized the increase in the fair value of the modified warrants of $0.2 million as a deemed dividend through ~~accumulated~~Accumulated deficit with a corresponding increase in ~~additional~~Additional paid-in capital.

Warrants ~~Issued~~issued as ~~Compensation~~compensation

On September 17, 2019, a Company advisor was issued ~~2,500,000~~416,667 warrants with an exercise price of ~~$0.10~~$0.60 per share and ~~1,500,000~~250,000 warrants with an exercise price of ~~$10.00~~$60.00 per share; ~~1,250,000~~208,334 of the ~~$0.10~~$0.60 exercise price warrants (the "Tranche 1 Warrants") were exercisable on the earlier of twelve-months after issuance date or immediately prior to a change in control subject to the advisor’s continued service and ~~1,250,000~~208,334 of the ~~$0.10~~$0.60 exercise price warrants (the "Tranche 2 Warrants") and the ~~1,500,000~~250,000 warrants with the ~~$10.00~~$60.00 exercise price (the "Tranche 3 Warrants") were exercisable on the earlier of eighteen-months after issuance or immediately prior to a change in control subject to the advisor’s continued service.

~~Table of Contents~~

On June 1, 2020, the Company entered into a termination agreement (the “Termination Agreement”) with the advisor. Pursuant to the terms of the Termination Agreement, the Tranche 1 Warrants were amended to reduce the number of shares of common stock purchasable thereunder to ~~1,041,666~~173,611 shares, and the Tranche 2 Warrants and Tranche 3 Warrants were cancelled. The Tranche 1 Warrants (as amended pursuant to the Termination Agreement) were fully vested as of the date of the termination of the agreement and will remain exercisable until September 17, 2029. Furthermore, if the Company engages in any restricted business line as defined in the Termination Agreement, the Company will issue to the former advisor additional shares of common stock based on formulas intended to compensate the former advisor for the warrants that were reduced or terminated. In connection with the Termination Agreement, the Company recorded expense of $5.7 million during the year ended December 31, 2020 in general and administrative expense. During the first quarter of 2021, the former advisor exercised ~~791,666~~131,945 of his remaining warrants outstanding in a cashless exercise resulting in ~~736,689~~122,782 shares of common stock issued.

On June 24, 2020, the Company issued ~~1,000,000~~166,667 warrants with an exercise price of ~~$1.25~~$7.50 per share to 2 non-employee directors, which are exercisable commencing on the date of issuance and expire ~~on the earlier of (i)~~ 84 months from the date of the consummation of an ~~underwritten public offering or other up-list transaction or (ii) June 30, 2030.~~IPO, which occurred July 1, 2021. On July 20, 2020, the Company issued ~~200,000~~33,334 warrants to 2 non-employee directors at a price of ~~$1.05~~$6.30 per share (the "July 2020 Director Warrants"), which are exercisable commencing on the date of issuance and expire ~~on the earlier of (i)~~ 84 months from the date of the consummation of an ~~underwritten public offering or other up-list transaction or (ii) June 30, 2030.~~IPO, which occurred July 1, 2021. The warrants issued to the non-employee directors were immediately vested and as such, the Company recorded $1.0 million of share-based compensation expense upon issuance.

On November 30, 2020, the Company issued ~~400,000~~66,667 warrants to a third-party for services with an exercise price of ~~$1.00~~$6.00 and an expiration date 72 months after issuance. These warrants were immediately vested and as such, the Company recorded $0.1 million in general and administrative expense.

Note 12 - Share-based compensation

During the three and nine months ended ~~March 31,~~September 30, 2021 the Company recognized $0.7 million and ~~March 31,~~$3.5 million, respectively, of share-based compensation expense. During the three and nine months ended September 30, 2020, the Company recognized ~~$2.5~~$1.5 million and ~~$2.5~~$7.0 million, respectively, of share-based compensation expense.

On November 11, 2019, the Company received shareholder approval for the Amended and Restated 2019 Incentive Award Plan (the “Amended 2019 Plan”). The Amended 2019 Plan provides for the grant of stock options, stock appreciation rights, restricted stock, restricted stock units, other stock or cash-based awards or a dividend equivalent award. The Amended 2019 Plan authorized the issuance ~~6,500,000~~1,083,334 shares of common stock which was increased to ~~9,000,000~~1,500,000 after the Halo acquisition; the Amended 2019 Plan also provides for an annual increase on the first day of each calendar year beginning on January 1, 2021 and ending on and including January 1, 2029, equal to the lesser of (A) 10% of the shares of common stock outstanding (on an as-converted basis) on the last day of the immediately preceding fiscal year and (B) such smaller number of shares of common stock as determined by the Board. ~~On January 1, 2021, the~~The total number of shares currently authorized for issuance ~~increased to 13,500,000, as approved by~~under the ~~Board.~~Amended 2019 Plan is 2,700,000.

Stock ~~Options~~options

Options granted under the Amended 2019 Plan vest over a period of two to three years. All vested options are exercisable and may be exercised through a ten-year anniversary of the grant date (or such earlier date described in the applicable award agreement).The fair value of an option award is estimated on the date of grant using the Black–Scholes option valuation model. During the ~~three~~nine months ended ~~March 31,~~September 30, 2021 and ~~March 31,~~September 30, 2020, the Company granted ~~5,579,000~~1,429,408 and ~~100,000~~50,002 stock options, ~~respectively.~~respectively under the Amended 2019 Plan.

Table of Contents

Restricted ~~Stock~~stock

In March 2020, the Company issued ~~450,000~~75,000 shares of restricted common stock to 3 non-employee directors in return for services provided in their capacity as directors and issued ~~5,956~~993 restricted shares of common stock to an officer of the Company. The restricted shares were immediately vested and as such, the Company recorded share-based compensation expense of $0.5 million upon issuance.

Note ~~13-~~13 - Income taxes

For the three and nine months ended ~~March 31,~~September 30, 2021 and ~~March 31,~~September 30, 2020, the Company recorded 0no income tax expense. For the three and nine months ended ~~March 31,~~September 30, 2021 and ~~March 31,~~September 30, 2020, the Company’s effective tax rate was 0%. The Company’s effective tax rate of 0% differs from the United States federal statutory rate of 21% ~~primarily~~due to permanent differences attributable to the change in the fair value of the warrant liabilities and because the Company’s losses have been fully offset by a valuation allowance due to uncertainty of realizing the tax benefit of net operating losses ("NOLs”) for the ~~three~~nine months ended ~~March 31,~~September 30, 2021 and for the year ended December 31, 2020.

~~Table of Contents~~

The Company’s deferred tax assets attributed to net operating loss carryforwards begin to expire in 2027. The ultimate realization of deferred taxes is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. On the basis of management’s assessment, a valuation allowance equal to the net deferred tax assets was recorded since it is more likely than not that the deferred tax assets will not be realized.

The Company has 0 accrued interest and penalties related to uncertain income tax positions. We do not anticipate that the amount of unrecognized tax benefits will significantly increase or decrease within the next twelve months. As of March 31, 2021 and December 31, 2020, the Company did not have any significant uncertain tax positions.

~~The Company’s income tax returns generally remain open for examination for three years from the date filed with each taxing jurisdiction.~~

Note 14 - Concentrations

Major ~~Suppliers~~suppliers

The Company sourced approximately ~~71%~~76% of its inventory purchases from three vendors for the ~~three~~nine months ended ~~March 31,~~September 30, 2021. The Company sourced approximately ~~48%~~78% of its inventory purchases from ~~two~~three vendors for the ~~three~~nine months ended ~~March 31,~~September 30, 2020.

Major ~~Customers~~customers

Accounts receivable from ~~two~~three customers represented ~~63%~~86% of accounts receivable as of ~~March 31,~~September 30, 2021. Accounts receivable from two customers represented 72% of accounts receivable as of December 31, 2020. ~~Two~~Three customers represented ~~42%~~54% of gross sales for the ~~three~~nine months ended ~~March 31,~~September 30, 2021. ~~Four~~Two customers represented ~~70%~~35% of gross sales for the ~~three~~nine months ended ~~March 31,~~September 30, 2020.

Credit ~~Risk~~risk

At ~~March 31,~~September 30, 2021 and December 31, 2020, the Company’s cash and cash equivalents were deposited in accounts at several financial institutions and may maintain some balances in excess of federally insured limits. The Company maintains its cash and cash equivalents with high-quality, accredited financial institutions and, accordingly, such funds are subject to minimal credit risk. The Company has not experienced any losses historically in these accounts and believes it is not exposed to significant credit risk in its cash and cash equivalents.

Note 15 - ~~Net loss~~Earnings (loss) per share

~~Basic~~The Company presents earnings (loss) per share on a basic and diluted ~~net loss~~basis. Basic earnings (loss) per share ~~attributable to~~is computed by dividing net income (loss) by the weighted average number of common ~~stockholders is presented~~shares outstanding during the period. Diluted earnings (loss) per share includes the dilutive effect of common stock equivalents, consisting of stock options and warrants using the treasury stock method and convertible notes and preferred stock using the if-converted method. Under the treasury stock method, the amount the ~~employee~~holder must pay for exercising stock options or warrants and the amount of average compensation cost for future service that has not yet been recognized are collectively assumed to be used to repurchase shares.

~~Basic~~As the Company reported net income for the nine months ended September 30, 2021, basic and diluted ~~net loss~~earnings per share isare calculated ~~by dividing net and comprehensive loss attributable to~~as outlined above. For the nine months ended September 30, 2021, the weighted average diluted common ~~stockholders by~~shares had 5,397,048 common stock equivalents excluded based on the ~~weighted-average shares outstanding during the period.~~fact that their inclusion would have had an anti-dilutive effect on earnings per share. For the three months ended ~~March 31,~~September 30, 2021 and for the three and nine months ended September 30, 2020, the Company’s basic and diluted net ~~and comprehensive~~ loss per share attributable to common stockholders are the same because the Company ~~has~~ generated a net loss ~~to common stockholders~~ and common stock equivalents are excluded from diluted net loss per share as they have an antidilutive impact.

Table of Contents

The following table sets forth basic and diluted net ~~loss~~income (loss) per share attributable to common stockholders for the three and nine months ended ~~March 31,~~September 30, 2021 and 2020 (in thousands, except share and per share amounts):


		Three Months Ended March 31,				Nine Months Ended September 30,				Three Months Ended September 30,
Common stockholders	Common stockholders	2021		2020			Common stockholders	2021		2020		2021		2020
Basic earnings (loss) per share:							Basic earnings (loss) per share:
Numerator:	Numerator:						Numerator:
Net and comprehensive loss		$	(12,850)	$	(9,454)
Net income (loss)							Net income (loss)	$	8,470	$	(29,551)	$	(3,456)	$	(1,693)
Less: Preferred stock dividends	Less: Preferred stock dividends	0		34			Less: Preferred stock dividends	—		103		—		35
Less: Adjustment due to warrant modifications	Less: Adjustment due to warrant modifications	402		0			Less: Adjustment due to warrant modifications	402		—		—		—
Adjusted Net and comprehensive loss available to common stockholders		$	(13,252)	$	(9,488)
Adjusted net income (loss) available to common stockholders							Adjusted net income (loss) available to common stockholders	$	8,068	$	(29,654)	$	(3,456)	$	(1,728)
Denominator:	Denominator:						Denominator:
Weighted average shares used in computing net loss per share attributable to common stockholders, basic and diluted		57,525,054		48,526,396
Net loss per share attributable to common stockholders, basic and diluted		$	(0.23)	$	(0.20)
Weighted average shares used in computing net earnings (loss) per share attributable to common stockholders, basic							Weighted average shares used in computing net earnings (loss) per share attributable to common stockholders, basic	16,799,796		8,134,957		29,466,520		8,160,242
Net earnings (loss) per share attributable to common stockholders, basic							Net earnings (loss) per share attributable to common stockholders, basic	$	0.48	$	(3.65)	$	(0.12)	$	(0.21)

Dilutive earnings (loss) per share:							Dilutive earnings (loss) per share:
Numerator:							Numerator:
Net income (loss)							Net income (loss)	$	8,470	$	(29,551)	$	(3,456)	$	(1,693)
Less: Preferred stock dividends							Less: Preferred stock dividends	—		103		—		35
Less: Adjustment due to warrant modifications							Less: Adjustment due to warrant modifications	402		—		—		—

Adjusted net income (loss) available to common stockholders							Adjusted net income (loss) available to common stockholders	$	8,068	$	(29,654)	$	(3,456)	$	(1,728)
Denominator:							Denominator:
Weighted average shares used in computing net earnings (loss) per share attributable to common stockholders, basic							Weighted average shares used in computing net earnings (loss) per share attributable to common stockholders, basic	16,799,796		8,134,957		29,466,520		8,160,242
Dilutive common stock equivalents							Dilutive common stock equivalents	6,885,555		—		—		—
Weighted average shares used in computing net earnings (loss) per share attributable to common stockholders, diluted							Weighted average shares used in computing net earnings (loss) per share attributable to common stockholders, diluted	23,685,351		8,134,957		29,466,520		8,160,242
Net earnings (loss) per share attributable to common stockholders, diluted							Net earnings (loss) per share attributable to common stockholders, diluted	$	0.34	$	(3.65)	$	(0.12)	$	(0.21)

2223

Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion includes forward-looking statements about our business, financial condition and results of operations, including discussions about management’s expectations for our business. The financial condition, results of operations and cash flows discussed in this Management’s Discussion and Analysis of Financial Condition and Results of Operations are those of Better Choice Company Inc. and its consolidated subsidiaries, collectively, the “Company,” “Better Choice Company,” “we,” “our,” or “us”. These statements represent projections, beliefs, and expectations based on current circumstances and conditions and in light of recent events and trends, and you should not construe these statements either as assurances of performance or as promises of a given course of action. Instead, various known and unknown factors are likely to cause our actual performance and management’s actions to vary, and the results of these variances may be both material and adverse. Accordingly, readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management’s analysis only as of the date hereof. We undertake no obligation to publicly release the results of any revision to these forward-looking statements which may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Overview and ~~Outlook~~outlook

We are ~~an animal~~a pet health and wellness company ~~ready to lead the global industry shift toward~~focused on providing pet products and services that help dogs and cats live healthier, happier and longer lives. Our mission is to become the most innovative premium pet food company in the world, and we are motivated by our commitment to making products with integrity and treating pets and their parents with respect. We believe our portfolio of brands are well positioned to benefit from the trends of growing pet humanization and an increased consumer focus on health and wellness, and we have adopted a laser focused, channel-specific approach to growth that is driven by new product innovation. Our executive team has a proven history of success in both the pet and consumer-packaged goods ~~and has~~industries, with over 50 years of combined experience in the pet industry and over 100 years of combined experience in the consumer-packaged goods industry.

Our product offering is sold today under the Halo and TruDog brands and has enabled ~~the Company~~us to penetrate multiple channels of trade, which we believe enables us to deliver on core consumer needs and respond to changing channel dynamics that have ~~only~~ accelerated as a result of the COVID-19 pandemic. We group these channels of trade into four distinct categories: E-Commerce, which includes the sale of product to online retailers such as Amazon and Chewy; Brick & Mortar, which includes the sale of product to pet specialty chains such as Petco, PetSmart, select grocery chains and neighborhood pet stores; DTC, which includes the sale of product through our online web platform; and International, which includes the sale of product to foreign distribution partners and to select international retailers. We believe our omni-channel approach is a significant competitive advantage, as it allows us to design and sell products purpose-built for success in specific channels while maintaining our ability to leverage marketing and sales resources cross-channel.

Although the COVID-19 pandemic has dramatically changed the U.S. retail landscape, the pet industry has proven to be resilient, with Packaged Facts recently increasing their projected 2021 growth rate for U.S. retail sales of pet food and supplies from 5.3% to 7.6%. While the industry-wide E-Commerce sales have retreated somewhat following the March 2020 pantry stocking, the sale of pet food and supplies online has increased 35% year-over-year according to Packaged Facts, with subscription sales nearly equal to the March 2020 peak. We anticipate our ability to reach a growing base of diverse customers online will ~~only~~ increase as ~~approximately 59%~~the majority of our sales ~~during fiscal year 2020 and the first quarter of 2021 were made via~~are derived from our DTC and E-Commerce channels. ~~Conversely,~~At the same time, we believe that our long-established relationships with key Brick & Mortar customers will enable us to jointly launch new products in the future that are designed for in-store success.

In addition to our domestic sales channels, the Halo brand’s international sales grew by 95% in 2020, driven primarily by Halo’s ability to secure Product Import Registrations for 15 ~~Dog~~dog and ~~Cat Food Diets~~cat food diets from the Ministry of Agriculture and Rural Affairs of China (“MOA”) in June 2020. We believe that our growth in Asia is fueled by increasing levels of economic financial status and demand for premium, western manufactured products, with China representing the largest market opportunity for growth and 48% of Better Choice’s international sales in 2020. According to Euromonitor, the Chinese market for premium dry dog and cat food is anticipated to grow at a 20% CAGR and 28% CAGR, respectively, from 2015 through 2025. This growth rate is driven by dramatic increases in pet ownership, which has seen the number of dog-owning Chinese households increase from 12% in 2015 to 20% in 2020. On a relative basis, 67% of U.S. households owned a pet in 2020 according to the American Pet Products Association, suggesting that the Chinese pet market has significant room to grow in the foreseeable future.

New product innovation, through our own research and development activities as well as through acquisitions, represents the cornerstone of our growth plan, and our established supply and distribution infrastructure allows us to develop, manufacture and bring new products to market in generally under nine months. Our flexible and scalable outsourced manufacturing model also promotes innovation, as we are able to offer a wide variety of dog and cat food products under the Halo and TruDog brands that serve many different consumer needs. Founded in 1986, the Halo brand consists of a diversified, premium natural dog and cat portfolio, with products derived from real whole meat, no rendered meat meal and non-genetically modified (non-"GMO") fruits and vegetables, unlike many other kibble and canned products currently in the marketplace.

2324

Table of Contents

In addition to its dry kibble and canned wet food offering, Halo also has a successful line of freeze-dried treats for dogs and cats and a growing line of award-winning vegan products for dogs. Founded in 2013, the TruDog brand offers ultra-premium, freeze-dried raw dog food, toppers, treats and supplements sold predominantly on its DTC website. Freeze-dried raw dog food is one of the fastest growing ~~sub-category~~sub-categories of premium pet food, with Packaged Facts reporting 39% year-over-year growth in the sub-category in 2019. We believe that both brands are ~~well~~ positioned to take advantage of pet parents’ increasing desire to feed only the highest quality ingredients to their pets, and that there will continue to be innovative opportunities for brand consolidation over time.

Our marketing strategies are designed to clearly communicate to consumers ~~about~~ the benefits of our products and to build awareness of our brands. We deploy a broad set of marketing tools across various forms of media to reach consumers through multiple touch points and engage with a number of marketing agencies to develop content and product packaging. Our marketing initiatives include the use of social and digital marketing, Search Engine Optimization, email and SMS marketing, and paid media (Facebook, Instagram & YouTube), among other proven strategies to generate and convert sales prospects into loyal, satisfied customers. In addition to directly targeting and educating consumers of our products, we partner with ~~a number of~~both E-commerce platforms and retailers such as Amazon, Chewy and Petco to develop joint sales and marketing initiatives to increase sales and acquire new customers.

On February 2, 2019 and February 28, 2019, respectively, we entered into definitive agreements to acquire through stock exchange agreements, approximately 93% of the outstanding interest of TruPet LLC and all of the outstanding shares of Bona Vida, Inc., an emerging hemp-based CBD platform focused on developing a portfolio of brand and product verticals within the ~~animal~~pet health and wellness space. On May 6, 2019, Better Choice Company consummated the stock exchange transactions whereby TruPet LLC and Bona Vida, Inc. became wholly owned subsidiaries of Better Choice Company. For accounting and financial reporting purposes, the transaction was treated as a reverse acquisition whereby TruPet is considered the acquiror of Better Choice Company and Bona Vida, Inc. Thus, the historical financial information of the registrant is that of TruPet even though the legal registrant remains Better Choice Company.

On December 19, 2019, ~~the Company~~we acquired 100% of the issued and outstanding capital stock of Halo, Purely for Pets, Inc., in exchange for a combination of cash consideration, shares of our common stock, and convertible subordinated notes and accompanying stock purchase warrants.

Although Bona Vida remains a wholly owned subsidiary, we do not currently sell or market any CBD products, we do not currently own any CBD related inventory or raw materials and we do not currently have plans to re-enter the CBD market at this time.

The impact that the ongoing COVID-19 pandemic and related supply chain challenges will have on our consolidated results of operations is uncertain. Although we have not observed a material reduction in ~~sales~~demand as of ~~March~~September 2021 as a result of the COVID-19 pandemic, we have seen some impact to our revenue growth as a result of supply chain issues and a notable reduction in our safety stocks during the third quarter of 2021. We will continue to evaluate the nature and extent of ~~COVID-19’s~~the pandemic's impact to our business, consolidated results of operations, financial condition, and ~~liquidity, and our~~liquidity. Our results presented herein are not necessarily indicative of the results to be expected for future periods in 2021 or the full fiscal year. Management cannot predict the full impact of the COVID-19 pandemic on ~~the Company’s~~our sourcing, manufacturing and distribution of its products or to economic conditions generally, including the effects on consumer spending. The ultimate extent of the effects of the COVID-19 pandemic on ~~the Company~~us is highly uncertain and will depend on future developments, and such effects could exist for an extended period of time even after the pandemic might end.

Results of ~~Operations~~operations for the three and nine months ended ~~March 31,~~September 30, 2021 and 2020

The following table sets forth our consolidated results for the periods presented (in thousands):


		Three Months Ended March 31,									Three Months Ended September 30,								Nine Months Ended September 30,
		2021		2020		Change		%			2021		2020		Change		%		2021		2020		Change		%
Net sales	Net sales	$	10,830	$	12,226	$	(1,396)	(11)	%	Net sales	$	13,200	$	11,135	$	2,065	19	%	$	35,019	$	33,302	$	1,717	5	%
Cost of goods sold	Cost of goods sold	6,556		8,069		(1,513)		(19)	%	Cost of goods sold	8,762		6,678		2,084		31	%	22,407		20,563		1,844		9	%
Gross profit	Gross profit	4,274		4,157		117		3	%	Gross profit	4,438		4,457		(19)		—	%	12,612		12,739		(127)		(1)	%
Operating expenses:	Operating expenses:									Operating expenses:
General and administrative	General and administrative	4,551		8,245		(3,694)		(45)	%	General and administrative	3,727		3,545		182		5	%	11,778		23,158		(11,380)		(49)	%
Sales and marketing										Sales and marketing	4,018		2,650		1,368		52	%	9,619		6,847		2,772		40	%
Share-based compensation	Share-based compensation	2,525		2,485		40		2	%	Share-based compensation	660		1,543		(883)		(57)	%	3,517		7,047		(3,530)		(50)	%
Sales and marketing		2,336		1,959		377		19	%
Total operating expenses	Total operating expenses	9,412		12,689		(3,277)		(26)	%	Total operating expenses	8,405		7,738		667		9	%	24,914		37,052		(12,138)		(33)	%
Loss from operations	Loss from operations	$	(5,138)	$	(8,532)	$	3,394	(40)	%	Loss from operations	$	(3,967)	$	(3,281)	$	(686)	(21)	%	$	(12,302)	$	(24,313)	$	12,011	49	%

2425

Table of Contents

Net sales

We sell our products through online retailers, pet specialty retailers, our online portal directly to our consumers and internationally to foreign distribution partners (transacted in U.S. dollars). ~~During 2019,~~Generally, our net sales were primarily driven by our distribution of TruPet products through our DTC channel. However, with the acquisition of Halo, our sales became more diversified through the E-commerce, Brick & Mortar and International channels.

~~For many customers,~~ sales transactions are single performance obligations that are recorded at the time the product is shipped from our distribution centers and when control transfers. We ~~record~~offer a ~~revenue reserve based on past return rates~~variety of trade promotions, discounts and incentives to ~~account for customer returns.~~our customers, which impacts the transaction price of our products and our net sales accordingly. DTC net sales include revenue derived from ~~the sale of our products and related~~ shipping fees ~~offset by promotional discounts, refunds~~ and are net of loyalty points ~~earned. We offer a variety of promotions and incentives to our customers including daily discounts, multi-bag purchase discounts and coupon codes for initial purchases. For our DTC loyalty program, a~~earned (a portion of revenue is deferred at the time of the sale as points are earned ~~based on the relative stand-alone selling price,~~ and not recognized until the redemption of the ~~loyalty~~ points, ~~which do not expire. We have applied a redemption rate~~estimated based on historical ~~experience.~~experience). We record a revenue reserve based on historical return rates to account for customer returns.

Information about ~~the Company’s~~our revenue channels is as follows (in thousands):


		Three Months Ended March 31,									Three Months Ended September 30,								Nine Months Ended September 30,
		2021				2020					2021				2020				2021				2020
E-commerce	E-commerce	$	4,010	37	%	$	4,481	37	%	E-commerce	$	4,742	36	%	$	3,510	32	%	$	11,644	33	%	$	10,969	33	%
Brick & Mortar	Brick & Mortar	1,894		18	%	2,897		23	%	Brick & Mortar	1,816		14	%	1,953		17	%	5,408		16	%	6,725		20	%
DTC	DTC	2,436		22	%	2,804		23	%	DTC	2,363		18	%	2,672		24	%	7,140		20	%	8,198		25	%
International	International	2,490		23	%	2,044		17	%	International	4,279		32	%	3,000		27	%	10,827		31	%	7,410		22	%
Net Sales	Net Sales	$	10,830	100	%	$	12,226	100	%	Net Sales	$	13,200	100	%	$	11,135	100	%	$	35,019	100	%	$	33,302	100	%

Net sales ~~decreased $1.4~~increased $2.1 million, or ~~11%~~19%, to ~~$10.8~~$13.2 million for the three months ended ~~March 31,~~September 30, 2021 compared to ~~$12.2~~$11.1 million for the three months ended ~~March 31,~~September 30, 2020. Net sales increased $1.7 million, or 5%, to $35.0 million for the nine months ended September 30, 2021 compared to $33.3 million for the nine months ended September 30, 2020. The ~~decrease~~increase was driven by ~~lower E-Commerce sales due to higher than normal orders during the first quarter of 2020 due to increased warehouse stocking orders~~growth in ~~March 2020 associated with the COVID-19 pandemic. The decrease was also driven~~our International and E-commerce channels, partially offset by lower Brick & Mortar sales ~~due to the discontinuation of products with one~~as we reshuffle our product lineup ahead of our ~~pet specialty customers~~new product launch in 2022, and lower DTC sales driven by aan intentional decrease in marketing spend ~~with low return on investment. These decreases were partially offset~~as we expect to shift the focus of these investments to our longer-term DTC strategy, rather than chasing short term revenue gains. Our revenue growth has been negatively impacted throughout the year by ~~continued growth~~the supply chain issues being felt globally as the pandemic continues to present challenges. We are navigating through short-term shortages in ~~our international channel.~~raw materials as well as production delays stemming from supply shortages and labor constraints.

Key factors that we expect to affect our future sales growth include new product innovation, ~~and~~our new product launch, our expansion strategy in each of the sales ~~channels.~~channels and our key supplier relationships.

Cost of goods sold and Gross profit

Our products are manufactured to our specifications by contracted manufacturing plants using raw materials sourced by our contracted manufacturers. We design our packaging ~~in-house~~ for manufacture by third parties, and packaging is shipped directly to contracted manufacturing plants. We work with our co-manufacturers to secure a supply of raw materials that meet our specifications, such as USA farm-raised beef, GAP 2 certified cage-free whole chicken and associated broths, GAP 2 certified cage-free whole turkey and associated broths, MSC certified wild-caught salmon and MSC certified wild-caught whitefish and associated broths, and select non-GMO fruits and vegetables, such as peas, sweet potatoes and lentils. In addition to procuring raw materials that meet our formulation requirements, our contract manufacturers manufacture, test and package our products.

Cost of goods sold consists primarily of the cost of product obtained from third-party contract manufacturing plants, packaging materials, inventory freight for shipping product from third-party contract manufacturing plants to ~~our~~the warehouse and third-party ~~fulfillment and royalties.~~fulfillment. We review inventory on hand periodically to identify damages, slow moving inventory, and/or aged inventory. Based on the analysis, we record inventories at the lower of cost or net realizable value, with any reduction in value expensed as cost of goods sold.

We calculate gross profit as net sales, including any shipping revenue collected from our customers, less cost of goods sold. Our gross profit has been and will continue to be affected by a variety of factors, primarily product sales mix, volumes sold, discounts offered to newly acquired and recurring customers, the cost of our manufactured products, and the cost of freight from the manufacturer to the warehouse.

Table of Contents

Cost of goods sold ~~decreased $1.5~~increased $2.1 million, or ~~19%~~31%, to ~~$6.6~~$8.8 million for the three months ended ~~March 31,~~September 30, 2021 compared to ~~$8.1~~$6.7 million for the three months ended ~~March 31,~~September 30, 2020. As a percentage of revenue, cost of goods sold ~~decreased~~increased to ~~61%~~66% during the three months ended ~~March 31,~~September 30, 2021 compared to ~~66%~~60% for the three months ended ~~March 31, 2020, respectively.~~September 30, 2020. The ~~decrease~~increase was driven by cost increases from our primary suppliers as a result of broad-scale inflation in the industry. We are actively working with our co-manufacturing and freight partners as well as transitioning some of our primary suppliers to generate future cost savings. Additionally, we have taken price increases to our customers effective late in the third quarter to help cover cost increases. We will continue to refine and optimize our overall pricing strategy as we evaluate the future impact of inflation and align ourselves with the market.

Cost of goods sold increased $1.8 million, or 9%, to $22.4 million for the nine months ended September 30, 2021 compared to $20.6 million for the nine months ended September 30, 2020. As a percentage of revenue, cost of goods sold increased to 64% during the nine months ended September 30, 2021 compared to 62% for the nine months ended September 30, 2020. These results were driven by the cost increases as described above, partially offset by $0.9 million of non-cash expense related to the amortization of a purchase accounting adjustment to inventory recorded in connection with the Halo acquisition in the first quarter of ~~2020 and decrease in net sales.~~

~~Table of Contents~~

~~During the three months ended March 31, 2021, gross profit increased $0.1 million to $4.3 million from $4.2 million during the three months ended March 31,~~ 2020. Gross profit margin increased to 39% for the three months ended March 31, 2021 as compared to 34% for the three months ended March 31, 2020. The improvement in gross profit margin was impacted by the prior year inventory accounting adjustment discussed above, as well as lower warehouse related costs, partially offset by higher product costs.

Operating ~~Expenses~~expenses

General and administrative expenses include management and back office personnel compensation and bonuses, warrant expense, ~~corporate level~~ information technology related costs, rent, travel, professional service fees, costs related to merchant credit card fees, insurance, product development costs, shipping DTC orders to customers, ~~customer service and~~ warehousing costs and general corporate expenses. During the three months ended ~~March 31,~~September 30, 2021, general and administrative expenses increased $0.2 million, or 5%, to $3.7 million compared to $3.5 million for the three months ended September 30, 2020. The increase was driven by product development costs related to our new product innovation, increased investor relations and professional services costs related to our recent IPO and Board fees, offset by a reduction in rent expense as a result of prior lease terminations. Additionally, there was a shift in personnel compensation as there was an increase due to new hires in the current year, offset by a reduction due to the warehouse outsourcing in 2020 and other terminations in early 2021. During the nine months ended September 30, 2021, general and administrative expenses decreased ~~$3.6~~$11.4 million, or ~~45%~~49%, to ~~$4.6~~$11.8 million compared to ~~$8.2~~$23.2 million for the ~~three~~nine months ended ~~March 31,~~September 30, 2020. ~~The decrease~~In addition to the items discussed above, the nine-month period was ~~driven~~impacted by ~~a reduction in~~non-recurring warrant expense of ~~$2.5~~$10.0 million and contract termination costs ~~incurred during the first quarter of 2020~~ of $1.1 million aincurred in 2020, non-cash ~~reduction~~reductions of our sales tax liability ~~of $0.5 million and a decrease in professional fees of $0.2 million, all of which was~~during 2021, partially offset by ~~higher headcount related costs.~~

~~Share-based compensation includes expenses related to stock options~~lease termination and loss on sale of certain ~~warrants issued to employees and non-employee directors. During the three months ended March 31, 2021, share-based compensation remained flat at $2.5 million for the three months ended March 31,~~assets earlier in 2021, and ~~March 31, 2020.~~an overall decrease in legal fees.

Sales and marketing expenses include costs related to compensation for sales and customer service personnel, other costs related to the selling platform, as well as marketing, including paid media and content creation expenses. Marketing expenses consist primarily of ~~Facebook, Amazon~~social media and ~~other media~~digital ads and marketing tools, as well as other advertising and marketing costs, all geared towards acquiring new customers and building brand awareness. During the three months ended ~~March 31,~~September 30, 2021, sales and marketing expenses ~~including paid media,~~ increased ~~$0.3~~$1.3 million, or ~~19%~~52%, to ~~$2.3~~$4.0 million from ~~$2.0~~$2.7 million during the three months ended ~~March 31, 2020,~~September 30, 2020. During the nine months ended September 30, 2021, sales and marketing expenses increased $2.8 million, or 40%, to $9.6 million from $6.8 million during the nine months ended September 30, 2020. These increases were driven primarily by increased promotional spend in our E-Commerce and International sales channels and higher advertising and market research costs ~~partially offset by a decrease~~related to developing our new product line.

Share-based compensation includes expenses related to stock options, common stock issued in ~~headcount related costs.~~

~~Interest expense~~

connection with severance arrangements and certain warrants issued to employees and non-employee directors. During the three months ended ~~March 31,~~September 30, 2021, ~~interest expense~~share-based compensation decreased ~~$1.5 million to~~ $0.8 million, ~~from $2.3~~or 57%, to $0.7 million as compared to $1.5 million for the three months ended ~~March 31,~~September 30, 2020. During the nine months ended September 30, 2021, share-based compensation decreased $3.5 million, or 50%, to $3.5 million compared to $7.0 million for the nine months ended September 30, 2020. The decrease for both the three and nine months were driven by a lower monthly expense due to an overall decrease in the fair value of the outstanding options in 2021 as compared to 2020. The decrease for the nine months ended was also driven by certain restricted stock and warrant grants for which compensation expense was recognized immediately during the second quarter of 2020; this was partially offset by accelerated vesting on certain stock option grants and a common stock grant for compensation during the first quarter of 2021.

Table of Contents

Interest expense, net

Interest expense relates primarily to existing and prior indebtedness including term loans, lines of credit and subordinated convertible ~~notes.~~notes and during the nine months ended September 30, 2021 includes $1.4 million associated with the remaining discount on the June 2020 Notes, which was fully accreted to interest expense in connection with the conversion to common stock resulting from the commencement of the trading of our common stock on the NYSE. During the three months ended September 30, 2021, interest expense decreased $2.4 million to $0.1 million from $2.5 million for the three months ended September 30, 2020. During the nine months ended September 30, 2021, interest expense decreased $4.2 million to $3.1 million from $7.3 million for the nine months ended September 30, 2020. The overall reduction in interest expense was driven by a decrease in outstanding debt balances as well as a more favorable interest rate on our new Wintrust Credit Facility.

(Gain) Loss on extinguishment of debt, net

During the three months ended ~~March 31, 2021,~~September 30, 2020, we incurred a loss on extinguishment of debt of ~~$0.4~~$0.1 million, while there was no corresponding ~~expense~~activity for the three months ended ~~March 31, 2020.~~September 30, 2021. Loss on extinguishment of debt for the three months ended September 30, 2020 relates to extinguishment accounting applied in connection with us entering into the ABL Facility. During the nine months ended September 30, 2021, we incurred a gain on extinguishment of debt, net of a loss on extinguishment of debt, of $0.5 million, while there was a loss on extinguishment of debt of $0.1 million for the nine months ended September 30, 2020. Gain on extinguishment of debt for the nine months ended September 30, 2021 relates to extinguishment accounting applied in connection with forgiveness of our PPP Loans, partially offset by the loss on termination of a term loan and ABL Facility. Loss on extinguishment of debt for the nine months ended September 30, 2020 relates to extinguishment accounting applied in connection with us entering into the ABL Facility. See "Note 7 - Debt" for additional information.

Change in fair value of warrant liabilities

Common stock warrants classified as liabilities are revalued at each balance sheet date subsequent to the initial issuance and changes in the fair value are reflected in the ~~consolidated statement~~Condensed Consolidated Statements of ~~operations~~Operations as change in fair value of warrant liability. The change in fair value for the three andnine months ended ~~March 31,~~September 30, 2021 relates to the ~~increase~~decrease in the fair value of ~~common stock warrants issued in connection with~~ the Series F ~~Private Placement.~~Warrants. See "Note 11 - Warrants" for additional information.

Income taxes

Our income tax provision consists of an estimate of federal and state income taxes based on enacted federal and state tax rates, as adjusted for any allowable credits, deductions and uncertain tax positions as ~~the~~they arise. No provision has been made for federal and state income taxes prior to the date of the May Acquisitions as the proportionate share of TruPet’s income or loss was included in the personal tax returns of its members as TruPet was a limited liability company. Subsequent to the acquisitions, ~~the Company,~~we, as a corporation isare required to provide for income taxes.

During the three and nine months ended ~~March 31,~~September 30, 2021 and 2020, respectively, we did not record income tax expense due to the continued losses incurred by ~~the Company.~~us. The effective tax rate ~~subsequent to the acquisitions~~ is 0%, which differs from the U.S. Federal statutory rate of 21% asdue to permanent differences attributable to the change in the fair value of the warrant liabilities and because our ~~reported~~deferred tax assets arising from operating losses are offset by a valuation allowance due to uncertainty as to the realization of those ~~losses.~~deferred tax assets.

~~Table of Contents~~

Liquidity and ~~Capital Resources~~capital resources

Since our founding, we have financed our operations primarily through sales of member units while a limited liability company, and since becoming a corporation, through the sales of shares of our common stock, warrants, preferred stock, and loans. On ~~March 31,~~September 30, 2021 and December 31, 2020, we had cash and cash equivalents and restricted cash of ~~$4.4~~$33.3 million and $4.0 million, respectively.

In connection with our IPO, we issued and sold 8,000,000 shares of common stock at a price of $5.00 per share. On July 1, 2021 we received total net proceeds of approximately $36.2 million from the IPO, after deducting underwriting discounts and commissions of $2.8 million, and offering costs of approximately $1.0 million. Upon commencement of our common stock trading on the NYSE, all outstanding convertible notes were converted into 4,732,420 shares of common stock and upon consummation of the IPO, all shares of convertible preferred stock were converted into 5,764,533 shares of common stock.

We are subject to risks common in the pet wellness consumer market including, but not limited to, dependence on key personnel, competitive forces, successful marketing and sale of its products, the successful protection of its proprietary technologies, ability to grow into new markets, and compliance with government regulations. As of ~~March~~September 30, 2021, we have not experienced a significant adverse impact to our business, financial condition or cash flows resulting from the COVID-19 pandemic. However, uncertainties regarding the continued economic impact of COVID-19 are likely to result in sustained market turmoil, which could negatively impact our business, financial condition, and cash flows in the future.

Table of Contents

We have historically incurred losses and ~~have an accumulated deficit. We~~ expect to continue to generate operating losses and consume significant cash resources for the foreseeable ~~future. These conditions raise~~future; however, due to our high level of working capital and minimal debt after the IPO, we do not anticipate substantial doubt about our ability to continue as a going ~~concern, meaning that we may be unable to continue operations for the foreseeable future or realize assets and discharge liabilities in the ordinary course of operations.~~concern. We have implemented and continue to implement plans to achieve cost savings and other strategic objectives, ~~to address these conditions. We have achieved~~including realized cost savings from the consolidation of our third-party logistics operations and reduction of overhead costs and we expect to achieve further cost savings from the consolidation of third-party manufacturers and optimization of shipping costs. The business is focused on growing the most profitable channels while reducing investments in areas that are expected to have lower long-term benefits.

If we seek additional financing to fund our business activities in the future and there remains doubt about our ability to continue as a going concern, investors or other financing sources may be unwilling to provide additional funding on commercially reasonable terms or at all. If we are unable to raise the necessary funds when needed or achieve planned cost savings, or other strategic objectives are not achieved, we may not be able to continue our operations, or we could be required to modify our operations that could slow future growth. The accompanying interim condensed consolidated financial statements have been prepared assuming we will continue as a going concern, which contemplates the realization of assets and payments of liabilities in the ordinary course of business. Accordingly, the interim condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of asset carrying amounts or the amount of and classification of liabilities that may result should we be unable to continue as a going concern.

A summary of our cash flows is as follows (in thousands):


		Three Months Ended March 31,					Nine Months Ended September 30,
		2021		2020			2021		2020
Cash flows (used in) provided by:	Cash flows (used in) provided by:					Cash flows (used in) provided by:
Operating activities	Operating activities	$	(2,325)	$	(1,159)	Operating activities	$	(8,320)	$	(4,523)
Investing activities	Investing activities	—		(8)		Investing activities	(124)		(42)
Financing activities	Financing activities	2,697		500		Financing activities	37,716		4,112
Net increase (decrease) in cash and cash equivalents and restricted cash	Net increase (decrease) in cash and cash equivalents and restricted cash	$	372	$	(667)	Net increase (decrease) in cash and cash equivalents and restricted cash	$	29,272	$	(453)

Cash flows from ~~Operating Activities~~operating activities

Cash used in operating activities increased ~~$1.2~~$3.8 million, or ~~101%~~84%, during the ~~three~~nine months ended ~~March 31,~~September 30, 2021 compared to the ~~three~~nine months ended ~~March 31,~~September 30, 2020. ~~Net loss from operations adjusted for non-cash expenses was $2.7 million for the three months ended March 31, 2021 compared to $2.9 million for the comparable prior year period.~~ The increase in cash used in operating activities was driven by ~~higher~~a comparative increase in accounts receivable balances of ~~$1.7~~$3.1 million due to the timing of sales and collections, ~~and higher inventory spend of $1.5 million to maintain a steady level of inventory~~ as ~~compared to the first quarter of 2020, where a large reduction in inventory occurred due to the March 2020 pantry stocking~~well as increased costs related to ~~the COVID-19 pandemic, partially offset by an increase in accounts payable and other accrued expenses of $1.7 million.~~developing our new product line.

Cash flows from ~~Investing Activities~~investing activities

Cash used in investing activities was ~~$0.0~~$0.1 million during the ~~three~~nine months ended ~~March 31,~~September 30, 2021 and less than $0.1 million during the ~~three~~nine months ended ~~March 31, 2020.The~~September 30, 2020. The cash used in investing activities for is related to the purchase of property and equipment.

~~Table of Contents~~

Cash flows from ~~Financing Activities~~financing activities

Cash provided by financing activities was ~~$2.7~~$37.7 million for the ~~three~~nine months ended ~~March 31,~~September 30, 2021 compared to cash provided by financing activities of ~~$0.5~~$4.1 million during the ~~three~~nine months ended ~~March 31,~~September 30, 2020. The cash provided by financing activities for the ~~three~~nine months ended ~~March 31,~~September 30, 2021 was related to net proceeds from the IPO of $36.2 million, proceeds from the January Private Placement of $4.1 million and cash received from warrant exercises of ~~$1.3~~$1.7 million, partially offset by net payments on the term loans of ~~$2.1~~$2.4 million, net payments on the revolving line of credit of ~~$0.4~~$0.3 million, ~~and~~ $0.1 million in debt issuance ~~costs.~~costs, and $1.3 million related to share repurchases. Net cash provided by financing activities during the ~~three~~nine months ended ~~March 31,~~September 30, 2020 was related to proceeds from the revolving line of ~~credit.~~credit, proceeds related to the June 2020 Notes and proceeds related to the PPP Loans.

Indebtedness

~~Our~~As of September 30, 2021, our indebtedness ~~includes~~consisted of a term loan and a revolving credit ~~facility, various convertible notes payable, and PPP loans.~~facility. For additional details about the terms, covenants and restrictions contained in the Wintrust ~~Agreement and the subordinated convertible notes,~~Credit Facility, see "Note 7 - Debt" to our interim condensed consolidated financial statements included in this Quarterly Report on Form 10-Q.

~~Off-Balance Sheet Arrangements~~Off-balance sheet arrangements

We do not have any off-balance sheet arrangements, as defined by applicable regulations of the SEC, that are reasonably likely to have a current or future material effect on our financial condition, results of operations, liquidity, capital expenditures or capital resources.

Table of Contents

Critical ~~Accounting Policies~~accounting policies and ~~Significant Estimates~~significant estimates

In connection with the preparation of our unaudited condensed consolidated financial statements prepared in accordance with GAAP, we are required to make assumptions and estimates about future events, and apply judgments that affect the reported amount of assets, liabilities, revenues, expenses and the related disclosures. We have identified critical accounting policies and significant estimates that, as a result of the judgments, uncertainties, uniqueness and complexities of the underlying accounting standards and operations involved could result in material changes to its financial condition or results of operations under different conditions or using different assumptions. Our most critical accounting policies are related to accounting for warrants, share-based compensation, accounting for convertible notes, goodwill impairment, revenue recognition, accounting for business combinations and income taxes. There have been no material changes to our critical accounting policies and estimated compared to the descriptions in our Annual Report for the year ended December 31, 2020.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

~~The Company is~~We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and is not required to provide the information under this Item.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of ~~Disclosure Controls~~disclosure controls and ~~Procedures~~procedures

Management evaluated its internal control over financial reporting for the quarter ended ~~March 31,~~September 30, 2021. Based upon that evaluation and as a result of the remediation of previously identified material weaknesses, as described in our most recent Annual Report, ~~the Company’s~~our Chief Executive Officer and Principal Financial and Accounting Officer concluded that ~~the Company’s~~our disclosure controls and procedures were effective as of ~~March 31,~~September 30, 2021.

Changes in ~~Internal Control Over Financial Reporting~~internal control over financial reporting

As of ~~March 31,~~September 30, 2021, management concluded that the remediated controls were operating effectively. There were no other changes in internal control over financial reporting during the fiscal quarter ended ~~March 31,~~September 30, 2021 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

~~Table of Contents~~

PART II

ITEM 1. LEGAL PROCEEDINGS

From time to time, we may become involved in various lawsuits and legal proceedings, which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business. We are currently not aware of any such legal proceedings or claims that we believe will have a material adverse effect on our business, financial condition or operating results.

ITEM 1A. RISK FACTORS

~~There~~Other than otherwise noted below, there have been no material changes from the risk factors ~~disclosed~~described under the heading “Risk Factors” in ~~Item 1A. of Part 1 of our Annual Report for~~ the ~~fiscal year ended December 31, 2020. While~~Registration Statement on Form S-1/A filed on June 16, 2021 (the "IPO Registration Statement"). Other than noted below, while we believe there have been no material changes from the risk factors previously disclosed, ~~in our Annual Report,~~ you should carefully consider, in addition to the other information set forth in this report, the risk factors discussed in our ~~2020 Annual Report~~IPO Registration Statement that could materially affect our business, financial condition or future results. The risks described in our ~~Annual Report~~IPO Registration Statement are not the only risks facing our Company. In addition to risks and uncertainties inherent in forward-looking statements contained in this Report on Form 10-Q, additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.

Increases in sourcing, manufacturing and/or warehousing costs, supply shortages, and/or supply changes could have an adverse effect on our business, financial condition, and operating results.

Our products are sourced from a limited number of third-party suppliers, and as a result we may be subject to price fluctuations or demand disruptions. Our operating results would be negatively impacted by increases in the prices of our products, and we have no guarantees that prices will not rise. Increases in our supplier costs could have a material effect on our gross margins. We may not be able to pass increased prices on to customers, which could adversely affect our margins and operating results. Our ability to meet increases in demand may be impacted by our reliance on our suppliers and we are subject to the risk of shortages and long lead times. We may not be able to develop alternate sources in a timely manner. Therefore, we may not be able to source sufficient product on terms that are acceptable to us, or at all, which may undermine our ability to fill our orders in a timely manner.

Table of Contents

Additionally, product we receive from suppliers may not be of sufficient quality or free from damage, or such merchandise may be damaged during shipping or while stored in our fulfillment center. We may incur additional expenses and our reputation could be harmed if customers and potential customers believe that our merchandise does not meet their expectations, is not properly labeled or is damaged.

In addition, supply chains may be impacted by events outside of our control and limit our ability to procure timely delivery of our products. The loss of a significant supplier, an increase in supplier costs, or delays or disruptions in the delivery of product, could adversely impact our ability to generate future revenue and earnings and have an adverse effect on our business, financial condition, and operating results.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

~~We have previously disclosed all sales~~Purchases of ~~securities without registration under~~Equity Securities by the ~~Securities Act~~Issuer

The following table presents information with respect to our repurchases of ~~1933, as amended.~~Better Choice Company common stock during the three months ended September 30, 2021:


Period	Total Number of Shares Purchased	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs
July 1, 2021 to July 31, 2021	—	$	—	—	$	2,000,000
August 1, 2021 to August 31, 2021	206,689	$	3.64	206,689	$	1,246,801
September 1, 2021 to September 30, 2021	138,086	$	3.77	138,086	$	726,590
Total	344,775	$	3.69	344,775

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5 OTHER INFORMATION

None.

ITEM 6. EXHIBITS

The following exhibits are filed herewith.

EXHIBIT INDEX

Exhibit Exhibit Description Form File
No. Exhibit Filing
date
2.1
Agreement and Plan of Merger, dated February 28, 2019, by and among the Company, BBC Merger Sub, Inc. and Bona Vida, Inc.
8-K 333-161943 2.1 05/10/2019
2.2
First Amendment to Agreement and Plan of Merger, dated February 28, 2019, by and among the Company, BBC Merger Sub, Inc., and Bona Vida, Inc., dated May 3, 2019
8-K 333-161943 2.2 05/10/2019
2.3
Securities Exchange Agreement, dated February 2, 2019, by and among the Company, TruPet LLC and the members of TruPet LLC
8-K 333-161943 2.3 05/10/2019
2.4
First Amendment to Securities Exchange Agreement, dated February 2, 2019, by and among the Company, TruPet LLC and the members of TruPet LLC, dated May 6, 2019
8-K 333-161943 2.4 05/10/2019
2.5
Amended and Restated Stock Purchase Agreement, dated December 18, 2019, by and among the Company, Halo, Purely For Pets, Inc., Thriving Paws, LLC and HH-Halo LP
8-K 333-161943 2.1 12/26/2019
3.1
Certificate of Incorporation, dated January 1, 2019
10-Q 333-161943 3.1 04/15/2019
3.2
Certificate of Amendment to Certificate of Incorporation, dated February 1, 2019
10-Q 333-161943 3.2 04/15/2019
3.3
Certificate of Amendment to Certificate of Incorporation, dated March 13, 2019
8-K 333-161943 3.1 03/20/2019

~~Table of Contents~~

Exhibit Exhibit Description Form File
No. Exhibit Filing
date
3.4
Certificate of Amendment to Certificate of Incorporation, dated April 18, 2019
10-KT 333-161943 3.5 07/25/2019
3.5
Certificate of Amendment to Certificate of Incorporation, dated July 30, 2020
8-K 333-161943 99.1 07/30/2020
3.6
Certificate of Merger of Sport Endurance, Inc. with and into the Company
10-Q 333-161943 3.4 04/15/2019
3.7
Bylaws
10-Q 333-161943 3.5 04/15/2019
3.8
Amended and Restated Certificate of Designation for Series E Convertible Preferred Stock
8-K 333-161943 3.1 05/23/2019
3.9
Certificate of Designation for Series F Convertible Preferred Stock
8-K 333-161943 3.1 10/02/2020
4.1
Form of Common Stock Purchase Warrant in connection with the May 2019 private placement
8-K 333-161943 4.1 04/30/2019
4.2
Form of Tranche 1 Common Stock Purchase Warrant, dated September 17, 2019, by and between the Registrant and Bruce Linton
8-K 333-161943 4.1 09/23/2019
4.3
Form of Tranche 2 Common Stock Purchase Warrant, dated September 17, 2019, by and between the Company and Bruce Linton
8-K 333-161943 4.2 09/23/2019
4.4
Form of Additional Common Stock Purchase Warrant, dated September 17, 2019, by and between the Company and Bruce Linton
8-K 333-161943 4.3 09/23/2019
4.5
Form of Subordinated Convertible Promissory Note in connection with the November 2019 private placement
8-K 333-161943 4.1 11/15/2019
4.6
Form of Common Stock Purchase Warrant in connection with the November 2019 private placement
8-K 333-161943 4.2 11/15/2019
4.7
Form of Subscription Agreement, dated December 19, 2019, by and among the Company and the Halo Sellers
10-Q 333-161943 10.6 01/31/2020
4.8
Form of Subordinated Convertible Promissory Note, dated December 19, 2019, by and among the Company and the Halo Sellers listed on the signature pages thereto
10-Q 333-161943 4.7 01/31/2020
4.9
Form of Common Stock Purchase Warrant, dated December 19, 2019, by and among the Company and the Halo Sellers
10-Q 333-161943 4.8 01/31/2020
4.10
Form of Common Stock Purchase Warrant, dated December 19, 2019, by and among the Company and the Shareholder Personal Guarantors
10-Q 333-161943 4.10 01/31/2020
4.11
Form of Common Stock Purchase Warrant Agreement in connection with the December 2018 private placement
8-K 333-161943 4.1 12/13/2018
4.12
Registration Rights Agreement, dated May 6, 2019, by and among the Company and the persons listed on the signature pages thereto in connection with the May 2019 private placement
S-1 333-234349 10.2 10/28/2019
4.13
First Amendment, dated June 10, 2019, to Registration Rights Agreement, dated May 6, 2019, by and among the Company and the stockholders party thereto
S-1 333-234349 10.3 10/28/2019
4.14
Form of Subscription Agreement dated April 25, 2019 in connection with the May 2019 private placement
8-K 333-161943 10.1 04/30/2019
4.15
Registration Rights Agreement, dated as of May 6, 2019, by and among Better Choice Company Inc. and the former stockholders of Bona Vida listed on the signature pages thereto
8-K 333-161943 4.1 05/10/2019
4.16
Registration Rights Agreement, dated as of May 6, 2019, by and among Better Choice Company Inc. and the former member of TruPet listed on the signature pages thereto
8-K 333-161943 4.2 05/10/2019
4.17
Form of Registration Rights Agreement by and among the Company and the persons listed on the signature pages thereto in connection with the November 2019 private placement
8-K 333-161943 4.3 11/15/2019
4.18
Form of Subscription Agreement in connection with the November 2019 private placement
8-K 333-161943 10.1 11/15/2019
4.19†
Better Choice Company Inc. Amended and Restated 2019 Incentive Award Plan
10-K 333-161943 10.19 05/04/2020
4.20†
Form of 2019 Incentive Aware Plan Stock Option Agreement
S-1 333-234349 10.7 10/28/2019

~~Table of Contents~~

Exhibit Exhibit Description Form File
No. Exhibit Filing
date
4.21
Form of Common Stock Purchase Warrant in connection with the June 2020 private placement.
10-Q 333-161943 4.11 06/25/2020
4.22
Form of Subordinated Convertible Promissory Note in connection with the June 2020 private placement.
10-Q 333-161943 4.12 06/25/2020
4.23
Form of Subscription Agreement in connection with the June 2020 private placement.
10-Q 333-161943 4.13 06/25/2020
4.24
Form of Registration Rights Agreement by and among the Company and the persons listed on the signature pages thereto in connection with the June 2020 private placement.
10-Q 333-161943 4.14 06/25/2020
4.25
Form of Amendment to November 2019 Notes, Seller Notes and ABG Notes
10-Q 333-161943 4.15 8/14/2020
4.26
Form of July 2020 Common Stock Purchase Warrants
8-K 333-161943 10.5 07/21/2020
4.27
Form of Warrant in connection with the October 2020 Series F Private Placement
8-K 333-161943 4.1 10/02/2020
4.28
Form of Securities Purchase Agreement in connection with the October 2020 Series F Private Placement
8-K 333-161943 10.1 10/2/2020
4.29
Form of Registration Rights Agreement in connection with the October 2020 Series F Private Placement
8-K 333-161943 10.2 10/2/2020
4.30
Exchange Agreement by and between the Company and Cavalry Fund LP dated September 30, 2020
8-K 333-161943 10.3 10/2/2020
4.31
Form of First Amendment to Registration Rights Agreement in connection with the October 2020 Series F Private Placement
10-Q 333-161943 10.40 11/16/2020
4.32
Form of warrant in connection with the January 2021 Private Placement
S-1/A 333-251241 4.22 2/16/2021
4.33
Form of Securities Purchase Agreement in connection with the January 2021 Private Placement
S-1/A 333-251241 4.23 2/16/2021
4.34
Form of Registration Rights Agreement in connection with the January 2021 Private Placement
S-1/A 333-251241 4.24 2/16/2021
10.1†
Form of Indemnification Agreement by and among the Company and its officers and directors
S-1 333-234349 10.8 10/28/2019
10.2†
Employment Agreement, dated February 1, 2019, for David Lelong
8-K 333-161943 10.1 02/07/2019
10.3†
Employment Agreement, dated as of May 6, 2019, by and between the Company and Damian Dalla-Longa
10-Q 333-161943 10.6 10/09/2019
10.4†
Resignation Letter from Damian Dalla-Longa, dated February 5, 2020
8-K 333-161943 10.3 02/11/2020
10.5†
Amendment to Employment Agreement, dated February 10, 2020, by and between Damian Dalla-Longa and the Company
8-K 333-161943 10.4 02/11/2020
10.6†
Employment Agreement, dated as of May 6, 2019, by and between the Company and Lori Taylor
10-Q 333-161943 10.7 10/09/2019
10.7†
Separation Agreement, dated as of September 13, 2019, by and between the Company and Lori Taylor
10-K 333-161943 10.28 05/04/2020
10.8†
Employment Agreement, dated May 6, 2019, by and among the Company and Anthony Santarsiero
S-1 333-234349 10.11 10/28/2019
10.9†
Employment Agreement, dated June 29, 2019, by and among the Company and Andreas Schulmeyer
S-1 333-234349 10.12 10/28/2019
10.10†
Employment Agreement, dated December 19, 2019, by and between the Company, Werner von Pein, and Halo
8-K 333-161943 10.1 02/11/2020
10.11†
Amendment to Employment Agreement, dated February 10, 2020, by and between Werner von Pein and the Company
8-K 333-161943 10.2 02/11/2020
10.12†
Employment Agreement, dated October 8, 2020, by and between Sharla Cook and the Company
10-K 333-161943 10.12 3/30/2021
10.13†
Employment Agreement, dated September 27, 2020, by and between Robert Sauermann and the Company
10-K 333-161943 10.13 3/30/2021
10.14†
Employment Agreement, dated January 1, 2021, by and between Donald Young and the Company
10-K 333-161943 10.14 3/30/2021


Exhibit	Exhibit Description	Form	File No.	Exhibit	Filing date
2.1	Agreement and Plan of Merger, dated February 28, 2019, by and among the Company, BBC Merger Sub, Inc. and Bona Vida, Inc.	8-K	333-161943	2.1	05/10/2019
2.2	First Amendment to Agreement and Plan of Merger, dated February 28, 2019, by and among the Company, BBC Merger Sub, Inc., and Bona Vida, Inc., dated May 3, 2019	8-K	333-161943	2.2	05/10/2019
2.3	Securities Exchange Agreement, dated February 2, 2019, by and among the Company, TruPet LLC and the members of TruPet LLC	8-K	333-161943	2.3	05/10/2019
2.4	First Amendment to Securities Exchange Agreement, dated February 2, 2019, by and among the Company, TruPet LLC and the members of TruPet LLC, dated May 6, 2019	8-K	333-161943	2.4	05/10/2019
2.5	Amended and Restated Stock Purchase Agreement, dated December 18, 2019, by and among the Company, Halo, Purely For Pets, Inc., Thriving Paws, LLC and HH-Halo LP	8-K	333-161943	2.1	12/26/2019
3.1	Certificate of Incorporation, dated January 1, 2019	10-Q	333-161943	3.1	04/15/2019
3.2	Certificate of Amendment to Certificate of Incorporation, dated February 1, 2019	10-Q	333-161943	3.2	04/15/2019

Table of Contents

Exhibit Exhibit Description Form File
No. Exhibit Filing
date
10.15†
Separation and Retirement Agreement, Dated December 28, 2020 by and between Werner von Pein and the Company
8-K/A 333-161943 10.1 1/5/2021
10.16†
Employment Agreement, Dated December 28, 2020 by and between Scott Lerner and the Company
8-K/A 333-161943 10.2 1/5/2021
10.17
Loan and Security Agreement, dated as of January 6, 2021, by and between Old Plank Trail Community Bank, N.A. ("Lender") and Halo, Purely for Pets, Inc., a Delaware corporation ("Halo")
8-K 333-161943 10.1 1/11/2021
10.18
Revolving Promissory Note, dated as of January 6, 2021, issued by Halo in favor of Lender
8-K 333-161943 10.2 1/11/2021
10.19
Term Note A, dated as of January 6, 2021, issued by Halo in favor of Lender
8-K 333-161943 10.3 1/11/2021
10.20
Guaranty and Security Agreement, dated as of January 6, 2021, made by Better Choice Company Inc. (the "Company"), TruPet LLC, a Delaware limited liability company ("TruPet") and Bona Vida, Inc., a Delaware corporation ("Bona Vida"), in favor of Lender
8-K 333-161943 10.4 1/11/2021
10.21
Intellectual Property Security Agreement, dated as of January 6, 2021, executed and delivered by the Company, TruPet and Bona Vida in favor of Lender
8-K 333-161943 10.5 1/11/2021
10.22
Stock Pledge Agreement, dated as of January 6, 2021, executed and delivered by the Company in favor of Lender
8-K 333-161943 10.6 1/11/2021
10.23
Collateral Pledge Agreement, dated as of January 6, 2021, executed and delivered by John M. Word, III in favor of Lender
8-K 333-161943 10.7 1/11/2021
10.24
Agreement effective as of February 23, 2021 by and between Emerging Media Consulting, a Florida limited liability company, and Better Choice Company, Inc.
8-K 333-161943 10.1 2/18/2021
10.25
Terms and Conditions for Winning Media LLC effective as of February 17, 2021 by and between Winning Media LLC and Better Choice Company, Inc.
8-K 333-161943 10.2 2/18/2021
21.1
Subsidiaries of the Company
10-K 333-161943 21.1 3/30/2021
31.1*
Certification of Principal Executive Officer Pursuant to Rules 13a‑14(a) and 15d‑14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes‑Oxley Act of 2002.
31.2*
Certification of Principal Financial Officer Pursuant to Rules 13a‑14(a) and 15d‑14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes‑Oxley Act of 2002.
32.1*
Certifications of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes‑Oxley Act of 2002
101* The following materials from the Company's Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2021 formatted in Inline Extensible Business Reporting Language ("iXBRL"): (i) the Condensed Consolidated Balance Sheets, (ii) the Condensed Consolidated Statements of Operations, (iii) the Condensed Consolidated Statements of Stockholders Deficit, (iv) the Condensed Consolidated Statements of Cash Flows and (v) related notes, tagged as blocks of text and including detailed tags
104* Cover page from the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2021, formatted in iXBRL (included as Exhibit 101)


Exhibit	Exhibit Description	Form	File No.	Exhibit	Filing date
3.3	Certificate of Amendment to Certificate of Incorporation, dated March 13, 2019	8-K	333-161943	3.1	03/20/2019
3.4	Certificate of Amendment to Certificate of Incorporation, dated April 18, 2019	10-KT	333-161943	3.5	07/25/2019
3.5	Certificate of Amendment to Certificate of Incorporation, dated July 30, 2020	8-K	333-161943	99.1	07/30/2020
3.6	Certificate of Merger of Sport Endurance, Inc. with and into the Company	10-Q	333-161943	3.4	04/15/2019
3.7	Bylaws	10-Q	333-161943	3.5	04/15/2019
3.8	Amended and Restated Certificate of Designation for Series E Convertible Preferred Stock	8-K	333-161943	3.1	05/23/2019
3.9	Certificate of Designation for Series F Convertible Preferred Stock	8-K	333-161943	3.1	10/02/2020
3.10	Certificate of Cancellation of the Amended and Restated Certificate of Designation Preference and Rights of the for Series E Convertible Preferred Stock	S-1/A	333-256405	3.9	06/16/2021
4.1	Form of Common Stock Purchase Warrant in connection with the May 2019 private placement	8-K	333-161943	4.1	04/30/2019
4.2	Form of Tranche 1 Common Stock Purchase Warrant, dated September 17, 2019, by and between the Registrant and Bruce Linton	8-K	333-161943	4.1	09/23/2019
4.3	Form of Tranche 2 Common Stock Purchase Warrant, dated September 17, 2019, by and between the Company and Bruce Linton	8-K	333-161943	4.2	09/23/2019
4.4	Form of Additional Common Stock Purchase Warrant, dated September 17, 2019, by and between the Company and Bruce Linton	8-K	333-161943	4.3	09/23/2019
4.5	Form of Subordinated Convertible Promissory Note in connection with the November 2019 private placement	8-K	333-161943	4.1	11/15/2019
4.6	Form of Common Stock Purchase Warrant in connection with the November 2019 private placement	8-K	333-161943	4.2	11/15/2019
4.7	Form of Subscription Agreement, dated December 19, 2019, by and among the Company and the Halo Sellers	10-Q	333-161943	10.6	01/31/2020
4.8	Form of Subordinated Convertible Promissory Note, dated December 19, 2019, by and among the Company and the Halo Sellers listed on the signature pages thereto	10-Q	333-161943	4.7	01/31/2020
4.9	Form of Common Stock Purchase Warrant, dated December 19, 2019, by and among the Company and the Halo Sellers	10-Q	333-161943	4.8	01/31/2020
4.10	Form of Common Stock Purchase Warrant, dated December 19, 2019, by and among the Company and the Shareholder Personal Guarantors	10-Q	333-161943	4.10	01/31/2020
4.11	Form of Common Stock Purchase Warrant Agreement in connection with the December 2018 private placement	8-K	333-161943	4.1	12/13/2018
4.12	Registration Rights Agreement, dated May 6, 2019, by and among the Company and the persons listed on the signature pages thereto in connection with the May 2019 private placement	S-1	333-234349	10.2	10/28/2019
4.13	First Amendment, dated June 10, 2019, to Registration Rights Agreement, dated May 6, 2019, by and among the Company and the stockholders party thereto	S-1	333-234349	10.3	10/28/2019
4.14	Form of Subscription Agreement dated April 25, 2019 in connection with the May 2019 private placement	8-K	333-161943	10.1	04/30/2019
4.15	Registration Rights Agreement, dated as of May 6, 2019, by and among Better Choice Company Inc. and the former stockholders of Bona Vida listed on the signature pages thereto	8-K	333-161943	4.1	05/10/2019
4.16	Registration Rights Agreement, dated as of May 6, 2019, by and among Better Choice Company Inc. and the former member of TruPet listed on the signature pages thereto	8-K	333-161943	4.2	05/10/2019
4.17	Form of Registration Rights Agreement by and among the Company and the persons listed on the signature pages thereto in connection with the November 2019 private placement	8-K	333-161943	4.3	11/15/2019

Table of Contents


Exhibit	Exhibit Description	Form	File No.	Exhibit	Filing date
4.18	Form of Subscription Agreement in connection with the November 2019 private placement	8-K	333-161943	10.1	11/15/2019
4.19†	Better Choice Company Inc. Amended and Restated 2019 Incentive Award Plan	10-K	333-161943	10.19	05/04/2020
4.20†	Form of 2019 Incentive Aware Plan Stock Option Agreement	S-1	333-234349	10.7	10/28/2019
4.21	Form of Common Stock Purchase Warrant in connection with the June 2020 private placement.	10-Q	333-161943	4.11	06/25/2020
4.22	Form of Subordinated Convertible Promissory Note in connection with the June 2020 private placement.	10-Q	333-161943	4.12	06/25/2020
4.23	Form of Subscription Agreement in connection with the June 2020 private placement.	10-Q	333-161943	4.13	06/25/2020
4.24	Form of Registration Rights Agreement by and among the Company and the persons listed on the signature pages thereto in connection with the June 2020 private placement.	10-Q	333-161943	4.14	06/25/2020
4.25	Form of Amendment to November 2019 Notes, Seller Notes and ABG Notes	10-Q	333-161943	4.15	8/14/2020
4.26	Form of July 2020 Common Stock Purchase Warrants	8-K	333-161943	10.5	07/21/2020
4.27	Form of Warrant in connection with the October 2020 Series F Private Placement	8-K	333-161943	4.1	10/02/2020
4.28	Form of Securities Purchase Agreement in connection with the October 2020 Series F Private Placement	8-K	333-161943	10.1	10/2/2020
4.29	Form of Registration Rights Agreement in connection with the October 2020 Series F Private Placement	8-K	333-161943	10.2	10/2/2020
4.30	Exchange Agreement by and between the Company and Cavalry Fund LP dated September 30, 2020	8-K	333-161943	10.3	10/2/2020
4.31	Form of First Amendment to Registration Rights Agreement in connection with the October 2020 Series F Private Placement	10-Q	333-161943	10.40	11/16/2020
4.32	Form of warrant in connection with the January 2021 Private Placement	S-1/A	333-251241	4.22	2/16/2021
4.33	Form of Securities Purchase Agreement in connection with the January 2021 Private Placement	S-1/A	333-251241	4.23	2/16/2021
4.34	Form of Registration Rights Agreement in connection with the January 2021 Private Placement	S-1/A	333-251241	4.24	2/16/2021
10.1†	Form of Indemnification Agreement by and among the Company and its officers and directors	S-1	333-234349	10.8	10/28/2019
10.2†	Employment Agreement, dated February 1, 2019, for David Lelong	8-K	333-161943	10.1	02/07/2019
10.3†	Employment Agreement, dated as of May 6, 2019, by and between the Company and Damian Dalla-Longa	10-Q	333-161943	10.6	10/09/2019
10.4†	Resignation Letter from Damian Dalla-Longa, dated February 5, 2020	8-K	333-161943	10.3	02/11/2020
10.5†	Amendment to Employment Agreement, dated February 10, 2020, by and between Damian Dalla-Longa and the Company	8-K	333-161943	10.4	02/11/2020
10.6†	Employment Agreement, dated as of May 6, 2019, by and between the Company and Lori Taylor	10-Q	333-161943	10.7	10/09/2019
10.7†	Separation Agreement, dated as of September 13, 2019, by and between the Company and Lori Taylor	10-K	333-161943	10.28	05/04/2020
10.8†	Employment Agreement, dated May 6, 2019, by and among the Company and Anthony Santarsiero	S-1	333-234349	10.11	10/28/2019
10.9†	Employment Agreement, dated June 29, 2019, by and among the Company and Andreas Schulmeyer	S-1	333-234349	10.12	10/28/2019
10.10†	Employment Agreement, dated December 19, 2019, by and between the Company, Werner von Pein, and Halo	8-K	333-161943	10.1	02/11/2020
10.11†	Amendment to Employment Agreement, dated February 10, 2020, by and between Werner von Pein and the Company	8-K	333-161943	10.2	02/11/2020
10.12†	Employment Agreement, dated October 8, 2020, by and between Sharla Cook and the Company	10-K	333-161943	10.12	3/30/2021

Table of Contents

Exhibit

Exhibit Description

Form

File
No.

Exhibit

Filing
date

10.13†

Employment Agreement, dated September 27, 2020, by and between Robert Sauermann and the Company

10-K

333-161943

10.13

3/30/2021

10.14†

Employment Agreement, dated January 1, 2021, by and between Donald Young and the Company

10-K

333-161943

10.14

3/30/2021

10.15†

Separation and Retirement Agreement, Dated December 28, 2020 by and between Werner von Pein and the Company

8-K/A

333-161943

10.1

1/5/2021

10.16†

Employment Agreement, Dated December 28, 2020 by and between Scott Lerner and the Company

8-K/A

333-161943

10.2

1/5/2021

10.17

Loan and Security Agreement, dated as of January 6, 2021, by and between Old Plank Trail Community Bank, N.A. ("Lender") and Halo, Purely for Pets, Inc., a Delaware corporation ("Halo")

8-K

333-161943

10.1

1/11/2021

10.18

Term Note A, dated as of January 6, 2021, issued by Halo in favor of Lender

8-K

333-161943

10.3

1/11/2021

10.19

Guaranty and Security Agreement, dated as of January 6, 2021, made by Better Choice Company Inc. (the "Company"), TruPet LLC, a Delaware limited liability company ("TruPet") and Bona Vida, Inc., a Delaware corporation ("Bona Vida"), in favor of Lender

8-K

333-161943

10.4

1/11/2021

10.20

Intellectual Property Security Agreement, dated as of January 6, 2021, executed and delivered by the Company, TruPet and Bona Vida in favor of Lender

8-K

333-161943

10.5

1/11/2021

10.21

Stock Pledge Agreement, dated as of January 6, 2021, executed and delivered by the Company in favor of Lender

8-K

333-161943

10.6

1/11/2021

10.22

First Amendment to Loan and Security Agreement, dated as of January 6, 2021, by and between Old Plank Trail Community Bank, N.A. ("Lender") and Halo, Purely for Pets, Inc., a Delaware corporation ("Halo")

8-K

001-40477

10.1

8/17/2021

10.23

Revolving Promissory Note, dated as of August 13, 2021, issued by Halo in favor of Lender.

8-K

001-40477

10.2

8/17/2021

10.24

Deposit Account Pledge Agreement, dated as of August 13, 2021, executed and delivered by Halo in favor of Lender.

8-K

001-40477

10.3

8/17/2021

21.1

Subsidiaries of the Company

S-1

333-256405

21.1

5/21/2021

31.1*

Certification of Principal Executive Officer Pursuant to Rules 13a‑14(a) and 15d‑14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes‑Oxley Act of 2002.

31.2*

Certification of Principal Financial Officer Pursuant to Rules 13a‑14(a) and 15d‑14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes‑Oxley Act of 2002.

32.1*

Certifications of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes‑Oxley Act of 2002

101*

The following materials from the Company's Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2021 formatted in Inline Extensible Business Reporting Language ("iXBRL"): (i) the Condensed Consolidated Balance Sheets, (ii) the Condensed Consolidated Statements of Operations, (iii) the Condensed Consolidated Statements of Stockholders Equity (Deficit), (iv) the Condensed Consolidated Statements of Cash Flows and (v) related notes, tagged as blocks of text and including detailed tags

104*

Cover page from the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2021, formatted in iXBRL (included as Exhibit 101)

† Indicates a management contract or any compensatory plan, contract or arrangement.

* Filed or furnished herewith.

# Certain schedules and similar attachments to this agreement have been omitted in accordance with Item 601(b)(5) of Regulation S-K. The Company will furnish copies of any schedules or similar attachments to the SEC upon request.

*** Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.

3234

Table of Contents

SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


	BETTER CHOICE COMPANY INC.

Date: ~~May 13,~~November 10, 2021	By:	/s/ SCOTT LERNER

		Scott Lerner
		Chief Executive Officer (Principal Executive Officer)

Date: ~~May 13,~~November 10, 2021	By:	/s/ SHARLA A. COOK

		Sharla A. Cook
		Chief Financial Officer (Principal Financial and Accounting Officer)

3335